BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossi S, Di Stasi M, Buscarini E, Quaretti P, Garbagnati F, Squassante L, Paties CT, Silverman DE, Buscarini L. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. American Journal of Roentgenology 1996;167:759-68. [DOI: 10.2214/ajr.167.3.8751696] [Cited by in Crossref: 558] [Cited by in F6Publishing: 460] [Article Influence: 22.3] [Reference Citation Analysis]
Number Citing Articles
1 Boaz TL, Lewin JS, Chung Y, Duerk JL, Clampitt ME, Haaga JR. MR monitoring of MR-guided radiofrequency thermal ablation of normal liver in an animal model. J Magn Reson Imaging 1998;8:64-9. [DOI: 10.1002/jmri.1880080115] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 3.1] [Reference Citation Analysis]
2 Yoshida H, Yoshida H, Shiina S, Omata M. Early liver cancer: concepts, diagnosis, and management. Int J Clin Oncol 2005;10:384-90. [DOI: 10.1007/s10147-005-0537-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shiozaki H. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 2004;183:153-6. [PMID: 15208130 DOI: 10.2214/ajr.183.1.1830153] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
4 Zhang W, Jiang L, Yan L, Yang J, Li B, Wen T, Zeng Y, Wang W, Xu M. Radiofrequency ablation for HCC patients with multifocal tumours meeting the Milan criteria: A single-centre experience. Digestive and Liver Disease 2016;48:1485-91. [DOI: 10.1016/j.dld.2016.07.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
5 Dodd GD. Radiofrequency Thermal Ablation of Hepatic Tumors. Journal of Vascular and Interventional Radiology 2000;11:118-9. [DOI: 10.1016/s1051-0443(00)70063-7] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
6 Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging. 2005;30:409-418. [PMID: 15688113 DOI: 10.1007/s00261-004-0255-7] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 6.0] [Reference Citation Analysis]
7 Steinke K. Lung Tumors. In: Stroszczynski C, editor. Minimally Invasive Tumor Therapies. Springer Berlin Heidelberg; 2006. pp. 107-22. [DOI: 10.1007/3-540-28137-1_8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 Ishikawa T, Imai M, Ko M, Sato H, Nozawa Y, Sano T, Iwanaga A, Seki K, Honma T, Yoshida T. Effect of treatment support on preventing local recurrence of hepatocellular carcinoma directly adjacent to the diaphragm. Mol Clin Oncol 2017;7:61-6. [PMID: 28685077 DOI: 10.3892/mco.2017.1257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Jiang Y, Kimchi ET, Montero AJ, Staveley-O’Carroll KF, Ajani JA. Upper gastrointestinal tumors: current status and future perspectives. Expert Rev Anticancer Ther. 2008;8:975-991. [PMID: 18533807 DOI: 10.1586/14737140.8.6.975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
10 Machi J, Oishi AJ, Mossing AJ, Furumoto NL, Oishi RH. Hand-assisted laparoscopic ultrasound-guided radiofrequency thermal ablation of liver tumors: a technical report. Surg Laparosc Endosc Percutan Tech 2002;12:160-4. [PMID: 12080255 DOI: 10.1097/00129689-200206000-00004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
11 Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242:158-171. [PMID: 16041205 DOI: 10.1097/01.sla.0000171032.99149.fe] [Cited by in Crossref: 503] [Cited by in F6Publishing: 423] [Article Influence: 31.4] [Reference Citation Analysis]
12 Chung MH, Wood TF, Tsioulias GJ, Rose DM, Bilchik AJ. Laparoscopic radiofrequency ablation of unresectable hepatic malignancies: A phase 2 trial. Surg Endosc 2001;15:1020-6. [DOI: 10.1007/s00464-001-0026-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
13 Hong K, Georgiades CS, Geschwind JF. Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques. Nat Clin Pract Oncol. 2006;3:315-324. [PMID: 16757969 DOI: 10.1038/ncponc0512] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
14 Cho YK, Rhim H, Ahn YS, Kim MY, Lim HK. Percutaneous Radiofrequency Ablation Therapy of Hepatocellular Carcinoma Using Multitined Expandable Electrodes: Comparison of Subcapsular and Nonsubcapsular Tumors. American Journal of Roentgenology 2006;186:S269-74. [DOI: 10.2214/ajr.04.1346] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
15 Lewin JS, Connell CF, Duerk JL, Chung YC, Clampitt ME, Spisak J, Gazelle GS, Haaga JR. Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging. 1998;8:40-47. [PMID: 9500259 DOI: 10.1002/jmri.1880080112] [Cited by in Crossref: 188] [Cited by in F6Publishing: 141] [Article Influence: 8.2] [Reference Citation Analysis]
16 Merkle EM, Boll DT, Boaz T, Duerk JL, Chung YC, Jacobs GH, Varnes ME, Lewin JS. MRI-guided radiofrequency thermal ablation of implanted VX2 liver tumors in a rabbit model: Demonstration of feasibility at 0.2 T. Magn Reson Med 1999;42:141-9. [DOI: 10.1002/(sici)1522-2594(199907)42:1<141::aid-mrm19>3.0.co;2-i] [Cited by in Crossref: 46] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
17 Leyendecker JR, Dodd GD 3rd, Halff GA, McCoy VA, Napier DH, Hubbard LG, Chintapalli KN, Chopra S, Washburn WK, Esterl RM, Cigarroa FG, Kohlmeier RE, Sharkey FE. Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation. AJR Am J Roentgenol 2002;178:1147-51. [PMID: 11959720 DOI: 10.2214/ajr.178.5.1781147] [Cited by in Crossref: 89] [Cited by in F6Publishing: 76] [Article Influence: 4.7] [Reference Citation Analysis]
18 Lee JM, Kim YK, Lee YH, Kim SW, Li CA, Kim CS. Percutaneous radiofrequency thermal ablation with hypertonic saline injection: in vivo study in a rabbit liver model. Korean J Radiol 2003;4:27-34. [PMID: 12679631 DOI: 10.3348/kjr.2003.4.1.27] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
19 Gallotti A, D’Onofrio M, Ruzzenente A, Martone E, De Robertis R, Guglielmi A, Pozzi Mucelli R. Contrast-enhanced ultrasonography (CEUS) immediately after percutaneous ablation of hepatocellular carcinoma. Radiol Med. 2009;114:1094-1105. [PMID: 19756947 DOI: 10.1007/s11547-009-0436-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
20 Ogawa T, Kawamoto H, Kobayashi Y, Nakamura S, Miyatake H, Harada R, Tsutsumi K, Fujii M, Kurihara N, Kato H. Prevention of biliary complication in radiofrequency ablation for hepatocellular carcinoma-Cooling effect by endoscopic nasobiliary drainage tube. Eur J Radiol. 2010;73:385-390. [PMID: 19056192 DOI: 10.1016/j.ejrad.2008.10.021] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
21 Nguyen MH, Keeffe EB. General management. Best Practice & Research Clinical Gastroenterology 2005;19:161-74. [DOI: 10.1016/j.bpg.2004.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
22 Ng KK, Poon RT. Radiofrequency ablation for malignant liver tumor. Surg Oncol. 2005;14:41-52. [PMID: 15777889 DOI: 10.1016/j.suronc.2005.01.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
23 Hänsler J, Frieser M, Tietz V, Uhlke D, Wissniowski T, Bernatik T, Hothorn T, Hahn EG, Strobel D. Percutaneous Radiofrequency Ablation of Liver Tumors Using Multiple Saline-Perfused Electrodes. Journal of Vascular and Interventional Radiology 2007;18:405-10. [DOI: 10.1016/j.jvir.2006.12.729] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
24 Yang W, Yan K, Wu GX, Wu W, Fu Y, Lee JC, Zhang ZY, Wang S, Chen MH. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes. World J Gastroenterol. 2015;21:1554-1566. [PMID: 25663774 DOI: 10.3748/wjg.v21.i5.1554] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
25 Haemmerich D, Wright AW, Mahvi DM, Lee FT, Webster JG. Hepatic bipolar radiofrequency ablation creates coagulation zones close to blood vessels: A finite element study. Med Biol Eng Comput 2003;41:317-23. [DOI: 10.1007/bf02348437] [Cited by in Crossref: 88] [Cited by in F6Publishing: 15] [Article Influence: 4.9] [Reference Citation Analysis]
26 Lu DSK, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of Vessel Size on Creation of Hepatic Radiofrequency Lesions in Pigs: Assessment of the “Heat Sink” Effect. American Journal of Roentgenology 2002;178:47-51. [DOI: 10.2214/ajr.178.1.1780047] [Cited by in Crossref: 330] [Cited by in F6Publishing: 276] [Article Influence: 17.4] [Reference Citation Analysis]
27 Seidenfeld J, Korn A, Aronson N. Radiofrequency ablation of unresectable primary liver cancer. J Am Coll Surg. 2002;194:813-828; discussion 828. [PMID: 12081073 DOI: 10.1016/s1072-7515(02)01180-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
28 Liu D, Brace CL. CT imaging during microwave ablation: analysis of spatial and temporal tissue contraction. Med Phys 2014;41:113303. [PMID: 25370671 DOI: 10.1118/1.4897381] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
29 Wong LL, Tanaka K, Lau L, Komura S. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers. Clin Transplant. 2004;18:227-234. [PMID: 15142041 DOI: 10.1111/j.1399-0012.2004.00164.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
30 Jeong YY, Mitchell DG, Hann HL, Malin AK, Kang HK, Holland GA, Capizzi RL. Hepatocellular Carcinoma After Systemic Chemotherapy: Gadolinium-Enhanced MR Measurement of Necrosis by Volume Histogram: . Journal of Computer Assisted Tomography 2001;25:624-8. [DOI: 10.1097/00004728-200107000-00019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
31 Weis S, Franke A, Mössner J, Jakobsen JC, Schoppmeyer K. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. Cochrane Database Syst Rev. 2013;12:CD003046. [PMID: 24357457 DOI: 10.1002/14651858.cd003046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
32 Zhang Y, White SB, Nicolai JR, Zhang Z, West DL, Kim DH, Goodwin AL, Miller FH, Omary RA, Larson AC. Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model. Radiology. 2014;271:721-729. [PMID: 24555632 DOI: 10.1148/radiol.14130989] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
33 Pacella CM, Bizzarri G, Magnolfi F, Cecconi P, Caspani B, Anelli V, Bianchini A, Valle D, Pacella S, Manenti G, Rossi Z. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology. 2001;221:712-720. [PMID: 11719667 DOI: 10.1148/radiol.2213001501] [Cited by in Crossref: 105] [Cited by in F6Publishing: 83] [Article Influence: 5.3] [Reference Citation Analysis]
34 Wang XL, Li K, Su ZZ, Huang ZP, Wang P, Zheng RQ. Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma. World J Gastroenterol 2015;21:5345-51. [PMID: 25954109 DOI: 10.3748/wjg.v21.i17.5345] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
35 Sato M, Tateishi R, Yasunaga H, Horiguchi H, Yoshida H, Matsuda S, Koike K. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol 2012;47:1125-33. [DOI: 10.1007/s00535-012-0569-0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 8.0] [Reference Citation Analysis]
36 Langenhoff B, Oyen W, Jager G, Strijk S, Wobbes T, Corstens F, Ruers T. Efficacy of Fluorine-18-Deoxyglucose Positron Emission Tomography in Detecting Tumor Recurrence After Local Ablative Therapy for Liver Metastases: A Prospective Study. JCO 2002;20:4453-8. [DOI: 10.1200/jco.2002.12.134] [Cited by in Crossref: 118] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
37 Lee MH, Ahn JM, Chung HW, Lim HK, Suh JG, Kwag HJ, Hong HP, Kim BM. Osteoid osteoma treated with percutaneous radiofrequency ablation: MR imaging follow-up. European Journal of Radiology 2007;64:309-14. [DOI: 10.1016/j.ejrad.2007.06.023] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
38 Chen TM, Huang PT, Lin LF, Tung JN. Major complications of ultrasound-guided percutaneous radiofrequency ablations for liver malignancies: single center experience. J Gastroenterol Hepatol. 2008;23:e445-e450. [PMID: 17683478 DOI: 10.1111/j.1440-1746.2007.05078.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
39 Brunello F, Veltri A, Carucci P, Pagano E, Ciccone G, Moretto P, Sacchetto P, Gandini G, Rizzetto M. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scand J Gastroenterol. 2008;43:727-735. [PMID: 18569991 DOI: 10.1080/00365520701885481] [Cited by in Crossref: 181] [Cited by in F6Publishing: 159] [Article Influence: 13.9] [Reference Citation Analysis]
40 Kamada K, Nakanishi T, Kitamoto M, Aikata H, Kawakami Y, Ito K, Asahara T, Kajiyama G. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrocholoride emulsion. J Vasc Intervent Radiol. 2001;12:847-854. [PMID: 11435541 DOI: 10.1016/s1051-0443(07)61510-3] [Cited by in Crossref: 57] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
41 Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, Fiore F, Pignata S, Daniele B, Cremona F. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1-8. [PMID: 10400029 DOI: 10.1097/00000658-199907000-00001] [Cited by in Crossref: 845] [Cited by in F6Publishing: 688] [Article Influence: 38.4] [Reference Citation Analysis]
42 Ishida K, Hirooka M, Hiraoka A, Kumagi T, Uehara T, Hiasa Y, Horiike N, Onji M. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil. Jpn J Clin Oncol 2008;38:596-603. [PMID: 18772170 DOI: 10.1093/jjco/hyn076] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
43 Tani S, Tatli S, Hata N, Garcia-Rojas X, Olubiyi OI, Silverman SG, Tokuda J. Three-dimensional quantitative assessment of ablation margins based on registration of pre- and post-procedural MRI and distance map. Int J Comput Assist Radiol Surg 2016;11:1133-42. [PMID: 27038962 DOI: 10.1007/s11548-016-1398-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
44 Erce C, Parks RW. Interstitial ablative techniques for hepatic tumours. Br J Surg. 2003;90:272-289. [PMID: 12594662 DOI: 10.1002/bjs.4091] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
45 Wu PH, Borden Z, Brace CL. Ablation zone visualization enhancement by periodic contrast-enhancement computed tomography during microwave ablation. Med Phys 2017;44:2132-40. [PMID: 28391605 DOI: 10.1002/mp.12266] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
46 Steinke K, King J, Glenn DW, Morris DL. Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: tips from preliminary experience. AJR Am J Roentgenol 2004;183:605-11. [PMID: 15333343 DOI: 10.2214/ajr.183.3.1830605] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
47 Zhang YJ, Chen MS. Role of radiofrequency ablation in the treatment of small hepatocellular carcinoma. World J Hepatol 2010;2:146-50. [PMID: 21160987 DOI: 10.4254/wjh.v2.i4.146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
48 Ng KK, Lam CM, Poon RT, Shek TW, Yu WC, To JY, Wo YH, Lau CP, Tang TC, Ho DW, Fan ST. Porcine liver: morphologic characteristics and cell viability at experimental radiofrequency ablation with internally cooled electrodes. Radiology 2005;235:478-86. [PMID: 15798156 DOI: 10.1148/radiol.2352040425] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
49 Lu MD, Chen JW, Xie XY, Liu L, Huang XQ, Liang LJ, Huang JF. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology. 2001;221:167-172. [PMID: 11568335 DOI: 10.1148/radiol.2211001783] [Cited by in Crossref: 140] [Cited by in F6Publishing: 116] [Article Influence: 7.0] [Reference Citation Analysis]
50 Cabassa P, Donato F, Simeone F, Grazioli L, Romanini L. Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes. AJR Am J Roentgenol. 2006;186:S316-S321. [PMID: 16632694 DOI: 10.2214/ajr.05.0243] [Cited by in Crossref: 46] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
51 Shiina S. Image-guided percutaneous ablation therapies for hepatocellular carcinoma. J Gastroenterol 2009;44:122-31. [DOI: 10.1007/s00535-008-2263-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
52 Zhou P, Liang P, Yu X, Wang Y, Dong B. Percutaneous microwave ablation of liver cancer adjacent to the gastrointestinal tract. J Gastrointest Surg. 2009;13:318-324. [PMID: 18825464 DOI: 10.1007/s11605-008-0710-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
53 Kim JS, Kim HS, Myung DS, Lee GH, Park KJ, Cho SB, Joo YE, Choi SK. A case of diaphragmatic hernia induced by radiofrequency ablation for hepatocellular carcinoma. Korean J Gastroenterol 2013;62:174-8. [PMID: 24077629 DOI: 10.4166/kjg.2013.62.3.174] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
54 Garcea G, Ong SL, Maddern GJ. Inoperable colorectal liver metastases: a declining entity? Eur J Cancer. 2008;44:2555-2572. [PMID: 18755585 DOI: 10.1016/j.ejca.2008.07.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
55 Lin SL, Chen ZR, Chang CA. Nd3+ sensitized core-shell-shell nanocomposites loaded with IR806 dye for photothermal therapy and up-conversion luminescence imaging by a single wavelength NIR light irradiation. Nanotheranostics 2018;2:243-57. [PMID: 29868349 DOI: 10.7150/ntno.25901] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 6.3] [Reference Citation Analysis]
56 Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, Okita K, Omata M, Kudo M, Kojiro M, Nakanuma Y, Takayasu K, Monden M, Matsuyama Y, Ikai I. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol. 2008;49:589-594. [PMID: 18620773 DOI: 10.1016/j.jhep.2008.05.018] [Cited by in Crossref: 124] [Cited by in F6Publishing: 115] [Article Influence: 9.5] [Reference Citation Analysis]
57 Ng KK, Lam CM, Poon RT, Ai V, Tso WK, Fan ST. Thermal ablative therapy for malignant liver tumors: a critical appraisal. J Gastroenterol Hepatol. 2003;18:616-629. [PMID: 12753142 DOI: 10.1046/j.1440-1746.2003.02991.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
58 Mulier S, Jiang Y, Jamart J, Wang C, Feng Y, Marchal G, Michel L, Ni Y. Bipolar radiofrequency ablation with 2 × 2 electrodes as a building block for matrix radiofrequency ablation: Ex vivo liver experiments and finite element method modelling. International Journal of Hyperthermia 2015;31:649-65. [DOI: 10.3109/02656736.2015.1046194] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
59 Senent SG, Raposo CG, Marcos NM, Chavarri SM, Alonso GC, Martín AO, Cabral JMS, Barón MG. Radiofrequency ablation for hepatocellular carcinoma and liver metastases: Experience in Hospital La Paz. Clin Transl Oncol 2006;8:688-91. [DOI: 10.1007/s12094-006-0040-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
60 Salmi A, Turrini R, Lanzani G, Savio A, Anglani L. Efficacy of radiofrequency ablation of hepatocellular carcinoma associated with chronic liver disease without cirrhosis. Int J Med Sci 2008;5:327-32. [PMID: 18974861 DOI: 10.7150/ijms.5.327] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
61 Goldberg SN, Dupuy DE. Image-guided Radiofrequency Tumor Ablation: Challenges and Opportunities—Part I. Journal of Vascular and Interventional Radiology 2001;12:1021-32. [DOI: 10.1016/s1051-0443(07)61587-5] [Cited by in Crossref: 255] [Cited by in F6Publishing: 50] [Article Influence: 12.8] [Reference Citation Analysis]
62 Klatte T, Kroeger N, Zimmermann U, Burchardt M, Belldegrun AS, Pantuck AJ. The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation. World J Urol. 2014;32:597-605. [PMID: 24700308 DOI: 10.1007/s00345-014-1284-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
63 Johnson A, Sprangers A, Cassidy P, Heyrman S, Hinshaw JL, Lubner M, Puccinelli J, Brace C. Design and validation of a thermoreversible material for percutaneous tissue hydrodissection. J Biomed Mater Res B Appl Biomater 2013;101:1400-9. [PMID: 24591222 DOI: 10.1002/jbm.b.32959] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
64 Kuvshinoff BW, Ota DM. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery. 2002;132:605-611; discussion 611-612. [PMID: 12407343 DOI: 10.1067/msy.2002.127545] [Cited by in Crossref: 152] [Cited by in F6Publishing: 130] [Article Influence: 8.0] [Reference Citation Analysis]
65 Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology. 2000;217:633-646. [PMID: 11110923 DOI: 10.1148/radiology.217.3.r00dc26633] [Cited by in Crossref: 538] [Cited by in F6Publishing: 433] [Article Influence: 26.9] [Reference Citation Analysis]
66 Gomaa AI, Waked I. Recent advances in multidisciplinary management of hepatocellular carcinoma. World J Hepatol. 2015;7:673-687. [PMID: 25866604 DOI: 10.4254/wjh.v7.i4.673] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
67 Miyayama S, Matsui O, Yamashiro M, Ryu Y, Kaito K, Ozaki K, Takeda T, Yoneda N, Notsumata K, Toya D, Tanaka N, Mitsui T. Ultraselective Transcatheter Arterial Chemoembolization with a 2-F Tip Microcatheter for Small Hepatocellular Carcinomas: Relationship Between Local Tumor Recurrence and Visualization of the Portal Vein with Iodized Oil. Journal of Vascular and Interventional Radiology 2007;18:365-76. [DOI: 10.1016/j.jvir.2006.12.004] [Cited by in Crossref: 162] [Cited by in F6Publishing: 132] [Article Influence: 11.6] [Reference Citation Analysis]
68 Ishikawa T. Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol. 2013;19:8861-8866. [PMID: 24379608 DOI: 10.3748/wjg.v19.i47.8861] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
69 Varghese T, Zagzebski J, Lee F. Elastographic imaging of thermal lesions in the liver in vivo following radiofrequency ablation: preliminary results. Ultrasound in Medicine & Biology 2002;28:1467-73. [DOI: 10.1016/s0301-5629(02)00656-7] [Cited by in Crossref: 135] [Cited by in F6Publishing: 45] [Article Influence: 7.1] [Reference Citation Analysis]
70 Pereira PL. Actual role of radiofrequency ablation of liver metastases. Eur Radiol 2007;17:2062-70. [PMID: 17429644 DOI: 10.1007/s00330-007-0587-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
71 Kosaka Y, Kawaoka T, Ogawa Y, Amioka K, Naruto K, Yoshikawa Y, Ando Y, Suehiro Y, Yamaoka K, Fujii Y, Uchikawa S, Ono A, Yamauchi M, Imamura M, Chosa K, Awai K, Nagata Y, Chayama K, Aikata H. Successful multimodality treatment for advanced hepatocellular carcinoma with tumor thrombosis of the main portal trunk: a case study. Clin J Gastroenterol 2021. [PMID: 34291386 DOI: 10.1007/s12328-021-01481-9] [Reference Citation Analysis]
72 Honda K, Seike M, Oribe J, Endo M, Arakawa M, Syo H, Iwao M, Tokoro M, Nishimura J, Mori T, Yamashita T, Fukuchi S, Muro T, Murakami K. Risk factors for deterioration of long-term liver function after radiofrequency ablation therapy. World J Hepatol 2016;8:597-604. [PMID: 27168872 DOI: 10.4254/wjh.v8.i13.597] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
73 Fontana RJ, Hamidullah H, Nghiem H, Greenson JK, Hussain H, Marrero J, Rudich S, McClure LA, Arenas J. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl. 2002;8:1165-1174. [PMID: 12474157 DOI: 10.1053/jlts.2002.36394] [Cited by in Crossref: 117] [Cited by in F6Publishing: 114] [Article Influence: 6.5] [Reference Citation Analysis]
74 Rhim H, Dodd GD, Chintapalli KN, Wood BJ, Dupuy DE, Hvizda JL, Sewell PE, Goldberg SN. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics. 2004;24:41-52. [PMID: 14730035 DOI: 10.1148/rg.241025144] [Cited by in Crossref: 213] [Cited by in F6Publishing: 167] [Article Influence: 12.5] [Reference Citation Analysis]
75 Rhim H, Goldberg SN, Dodd GD, Solbiati L, Lim HK, Tonolini M, Cho OK. Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics. 2001;21 Spec No:S17-35; discussion S36-9. [PMID: 11598245 DOI: 10.1148/radiographics.21.suppl_1.g01oc11s17] [Cited by in Crossref: 237] [Cited by in F6Publishing: 173] [Article Influence: 11.9] [Reference Citation Analysis]
76 Tsuda M, Rikimaru H, Majima K, Yamada T, Saito H, Ishibashi T, Takahashi S, Miyachi H, Endoh M, Yamada S. Time-Related Changes of Radiofrequency Ablation Lesion in the Normal Rabbit Liver: Findings of Magnetic Resonance Imaging and Histopathology: . Investigative Radiology 2003;38:525-31. [DOI: 10.1097/01.rli.0000073447.32361.b3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
77 Kim SK, Lim HK, Ryu JA, Choi D, Lee WJ, Lee JY, Lee JH, Sung YM, Cho EY, Hong SM, Kim JS. Radiofrequency ablation of rabbit liver in vivo: effect of the pringle maneuver on pathologic changes in liver surrounding the ablation zone. Korean J Radiol 2004;5:240-9. [PMID: 15637474 DOI: 10.3348/kjr.2004.5.4.240] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
78 Seror O, Haddar D, N'kontchou G, Ajavon Y, Trinchet J, Beaugrand M, Sellier N. Radiofrequency Ablation for the Treatment of Liver Tumors in the Caudate Lobe. Journal of Vascular and Interventional Radiology 2005;16:981-90. [DOI: 10.1097/01.rvi.0000159859.71448.8a] [Cited by in Crossref: 28] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
79 Weidensteiner C, Quesson B, Caire-gana B, Kerioui N, Rullier A, Trillaud H, Moonen CT. Real-time MR temperature mapping of rabbit liver in vivo during thermal ablation. Magn Reson Med 2003;50:322-30. [DOI: 10.1002/mrm.10521] [Cited by in Crossref: 90] [Cited by in F6Publishing: 66] [Article Influence: 5.0] [Reference Citation Analysis]
80 Neeman Z, Libutti SK, Patti JW, Wood BJ. Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis. Clin Imaging. 2003;27:417-420. [PMID: 14585572 DOI: 10.1016/s0899-7071(03)00015-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
81 Wiering B, Ruers TJ, Oyen WJ. Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases. Expert Rev Anticancer Ther. 2004;4:607-613. [PMID: 15270664 DOI: 10.1586/14737140.4.4.607] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
82 Lochab V, Jones TH, Alkandry E, West JD, Abdel-Rahman MH, Subramaniam VV, Prakash S. Evaluation of electrical properties of ex vivo human hepatic tissue with metastatic colorectal cancer. Physiol Meas 2020;41:085005. [PMID: 32909548 DOI: 10.1088/1361-6579/abaa55] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Pompili M, Rapaccini GL, Covino M, Pignataro G, Caturelli E, Siena DA, Villani MR, Cedrone A, Gasbarrini G. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy. Cancer 2001;92:126-35. [DOI: 10.1002/1097-0142(20010701)92:1<126::aid-cncr1300>3.0.co;2-v] [Cited by in Crossref: 59] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
84 Miyaki D, Aikata H, Kan H, Fujino H, Urabe A, Masaki K, Fukuhara T, Kobayashi T, Naeshiro N, Nakahara T. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy. J Gastroenterol Hepatol. 2013;28:1834-1841. [PMID: 23808713 DOI: 10.1111/jgh.12311] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
85 Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, Sarli D, Schiavo M, Garbagnati F, Marchianò A. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg. 2004;240:900-909. [PMID: 15492574 DOI: 10.1097/01.sla.0000143301.56154.95] [Cited by in Crossref: 356] [Cited by in F6Publishing: 312] [Article Influence: 20.9] [Reference Citation Analysis]
86 Solmi L, Nigro G, Roda E. Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma. World J Gastroenterol 2006;12:1098-104. [PMID: 16534852 DOI: 10.3748/wjg.v12.i7.1098] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
87 Crowley JD, Shelton J, Iverson AJ, Burton MP, Dalrymple NC, Bishoff JT. Laparoscopic and computed tomography-guided percutaneous radiofrequency ablation of renal tissue: acute and chronic effects in an animal model. Urology 2001;57:976-80. [DOI: 10.1016/s0090-4295(00)01129-8] [Cited by in Crossref: 89] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
88 Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST. Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol. 2004;11:281-289. [PMID: 14993023 DOI: 10.1245/ASO.2004.08.018] [Cited by in Crossref: 66] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
89 Lim HK. Radiofrequency thermal ablation of hepatocellular carcinomas. Korean J Radiol 2000;1:175-84. [PMID: 11752952 DOI: 10.3348/kjr.2000.1.4.175] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
90 Nour SG. MRI-guided and Monitored Radiofrequency Tumor Ablation1. Academic Radiology 2005;12:1110-20. [DOI: 10.1016/j.acra.2005.05.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
91 Katamura Y, Aikata H, Hashimoto Y, Kimura Y, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S. Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma. Hepatol Res. 2010;40:1195-1203. [PMID: 21040275 DOI: 10.1111/j.1872-034x.2010.00729.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
92 Scudamore CH, Lee SI, Patterson EJ, Buczkowski AK, July LV, Chung SW, Buckley AR, Ho SG, Owen DA. Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg. 1999;177:411-417. [PMID: 10365882 DOI: 10.1016/s0002-9610(99)00068-9] [Cited by in Crossref: 104] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
93 Sartori S, Tombesi P, Macario F, Nielsen I, Tassinari D, Catellani M, Abbasciano V. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Radiology. 2008;248:670-679. [PMID: 18519740 DOI: 10.1148/radiol.2482071690] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
94 Mori Y, Tamai H, Shingaki N, Moribata K, Shiraki T, Deguchi H, Ueda K, Enomoto S, Magari H, Inoue I. Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma. Hepatol Int. 2009;3:509-515. [PMID: 19669252 DOI: 10.1007/s12072-009-9131-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
95 Sato M, Tateishi R, Yasunaga H, Matsui H, Fushimi K, Ikeda H, Yatomi Y, Koike K. Association between hospital volume and in-hospital mortality following radiofrequency ablation for hepatocellular carcinoma. BJS Open 2017;1:50-4. [PMID: 29951606 DOI: 10.1002/bjs5.9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
96 Braga L, Semelka RC, Pedro MS, de Barros N. Post-treatment malignant liver lesions: MR imaging. Magnetic Resonance Imaging Clinics of North America 2002;10:53-73. [DOI: 10.1016/s1064-9689(03)00049-7] [Cited by in Crossref: 17] [Article Influence: 0.9] [Reference Citation Analysis]
97 Lubienski A, Düx M, Lubienski K, Grenacher L, Kauffmann G. Radiofrequency Thermal Ablation: Increase in Lesion Diameter with Continuous Acetic Acid Infusion. Cardiovasc Intervent Radiol 2005;28:789-94. [DOI: 10.1007/s00270-005-0022-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
98 Krasnick BA, Sindram D, Simo K, Goss R, Bharadwaj J, Howk K, Herdina KA, Hammill CW. Tumor Ablation Using 3-Dimensional Electromagnetic-Guided Ultrasound Versus Standard Ultrasound in a Porcine Model. Surg Innov 2019;26:420-6. [DOI: 10.1177/1553350619825717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol. 2013;63:486-492. [PMID: 22959191 DOI: 10.1016/j.eururo.2012.08.062] [Cited by in Crossref: 205] [Cited by in F6Publishing: 155] [Article Influence: 22.8] [Reference Citation Analysis]
100 Shi F, Tan Z, An H, Wang X, Xu Y, Wang S. Hepatocellular carcinoma ≤ 4 cm treated with radiofrequency ablation with or without percutaneous ethanol injection. Annals of Hepatology 2016;15:61-70. [DOI: 10.5604/16652681.1184219] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
101 Koniaris LG, Chan DY, Magee C, Solomon SB, Anderson JH, Smith DO, De Weese T, Kavoussi LR, Choti MA. Focal hepatic ablation using interstitial photon radiation energy. J Am Coll Surg 2000;191:164-74. [PMID: 10945360 DOI: 10.1016/s1072-7515(00)00295-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
102 Ihnát P, Ihnát Rudinská L, Zonča P. Radiofrequency energy in surgery: state of the art. Surg Today 2014;44:985-91. [PMID: 23728491 DOI: 10.1007/s00595-013-0630-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
103 Kim RY, Weintraub JL, Susman J, Haskal ZJ. Radiofrequency Ablation for Hemobilia Secondary to Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2002;13:317-20. [DOI: 10.1016/s1051-0443(07)61726-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
104 Nour SG, Aschoff AJ, Mitchell ICS, Emancipator SN, Duerk JL, Lewin JS. MR Imaging–guided Radio-frequency Thermal Ablation of the Lumbar Vertebrae in Porcine Models. Radiology 2002;224:452-62. [DOI: 10.1148/radiol.2242011269] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
105 Aschoff AJ, Merkle EM, Emancipator SN, Petersilge CA, Duerk JL, Lewin JS. Femur: MR imaging-guided radio-frequency ablation in a porcine model-feasibility study. Radiology 2002;225:471-8. [PMID: 12409582 DOI: 10.1148/radiol.2252001500] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
106 Schirmang TC, Dupuy DE. Image-guided thermal ablation of nonresectable hepatic tumors using the Cool-Tip™ radiofrequency ablation system. Expert Review of Medical Devices 2014;4:803-14. [DOI: 10.1586/17434440.4.6.803] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
107 Giorgio A, Tarantino L, de Stefano G N, Catalano O, Cusati B, Del Viscovo L A, Caturelli E. Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients. Eur J Ultrasound. 2000;11:181-188. [PMID: 10874193 DOI: 10.1016/s0929-8266(00)00086-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
108 Gillams AR. Liver ablation therapy. BJR 2004;77:713-23. [DOI: 10.1259/bjr/86761907] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
109 Hiraoka A, Ichiryu M, Tazuya N, Ochi H, Tanabe A, Nakahara H, Hidaka S, Uehara T, Ichikawa S, Hasebe A, Miyamoto Y, Ninomiya T, Hirooka M, Abe M, Hiasa Y, Matsuura B, Onji M, Michitaka K. Clinical translation in the treatment of hepatocellular carcinoma following the introduction of contrast-enhanced ultrasonography with Sonazoid. Oncol Lett 2010;1:57-61. [PMID: 22966256 DOI: 10.3892/ol_00000010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
110 Lee JD, Lee JM, Kim SW, Kim CS, Mun WS. MR imaging-histopathologic correlation of radiofrequency thermal ablation lesion in a rabbit liver model: observation during acute and chronic stages. Korean J Radiol. 2001;2:151-158. [PMID: 11752986 DOI: 10.3348/kjr.2001.2.3.151] [Cited by in Crossref: 91] [Cited by in F6Publishing: 74] [Article Influence: 4.8] [Reference Citation Analysis]
111 Liu Q, Ma K, He Z, Dong J, Hua X, Huang X, Qiao L. Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: a pilot study. J Gastrointest Surg. 2005;9:648-657. [PMID: 15862259 DOI: 10.1016/j.gassur.2004.11.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
112 Kuruppu D, Christophi C, Bertram JF, O'Brien PE. Tamoxifen inhibits colorectal cancer metastases in the liver: a study in a murine model. J Gastroenterol Hepatol 1998;13:521-7. [PMID: 9641652 DOI: 10.1111/j.1440-1746.1998.tb00680.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
113 Raman SS, Lu DS, Vodopich DJ, Sayre J, Lassman C. Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology. AJR Am J Roentgenol 2000;175:1253-8. [PMID: 11044017 DOI: 10.2214/ajr.175.5.1751253] [Cited by in Crossref: 93] [Cited by in F6Publishing: 81] [Article Influence: 4.4] [Reference Citation Analysis]
114 Tsuda M, Majima K, Yamada T, Saitou H, Ishibashi T, Takahashi S. Hepatocellular carcinoma after radiofrequency ablation therapy. Clinical Imaging 2001;25:409-15. [DOI: 10.1016/s0899-7071(01)00333-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
115 Nomura M, Yamakado K, Nomoto Y, Nakatsuka A, Ii N, Takaki H, Yamashita Y, Takeda K. Complications after lung radiofrequency ablation: risk factors for lung inflammation. Br J Radiol 2008;81:244-9. [PMID: 18208852 DOI: 10.1259/bjr/84269673] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
116 Kim TS, Lim HK, Lee KS, Yoon YC, Yi CA, Han D. Imaging-Guided Percutaneous Radiofrequency Ablation of Pulmonary Metastatic Nodules Caused by Hepatocellular Carcinoma: Preliminary Experience. American Journal of Roentgenology 2003;181:491-4. [DOI: 10.2214/ajr.181.2.1810491] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
117 Toso C, Mentha G, Kneteman NM, Majno P. The place of downstaging for hepatocellular carcinoma. J Hepatol. 2010;52:930-936. [PMID: 20385428 DOI: 10.1016/j.jhep.2009.12.032] [Cited by in Crossref: 88] [Cited by in F6Publishing: 74] [Article Influence: 8.0] [Reference Citation Analysis]
118 Chen X, Barkauskas KJ, Nour SG, Duerk JL, Abdul-karim FW, Saidel GM. Magnetic resonance imaging and model prediction for thermal ablation of tissue. J Magn Reson Imaging 2007;26:123-32. [DOI: 10.1002/jmri.20956] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
119 Guglielmi A, Ruzzenente A, Sandri M, Pachera S, Pedrazzani C, Tasselli S, Iacono C. Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg. 2007;11:143-149. [PMID: 17390163 DOI: 10.1007/s11605-006-0082-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
120 Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol. 2005;31:331-347. [PMID: 15837037 DOI: 10.1016/j.ejso.2004.10.011] [Cited by in Crossref: 93] [Cited by in F6Publishing: 77] [Article Influence: 5.8] [Reference Citation Analysis]
121 Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000;7:593-600. [PMID: 11005558 DOI: 10.1007/BF02725339] [Cited by in Crossref: 379] [Cited by in F6Publishing: 85] [Article Influence: 19.0] [Reference Citation Analysis]
122 Farnam JL, Smith BC, Johnson BR, Estrada R, Edelman TL, Farah R, Cressman EN. Thermochemical ablation in an ex-vivo porcine liver model using acetic acid and sodium hydroxide: proof of concept. J Vasc Interv Radiol 2010;21:1573-8. [PMID: 20801679 DOI: 10.1016/j.jvir.2010.06.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
123 Berber E, Siperstein AE. Laparoscopic Radiofrequency Ablation of Neuroendocrine Liver Metastases: . Problems in General Surgery 2003;20:134-42. [DOI: 10.1097/00013452-200309000-00015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
124 Choti MA. Surgical Management of Hepatocellular Carcinoma: Resection and Ablation. Journal of Vascular and Interventional Radiology 2002;13:S197-203. [DOI: 10.1016/s1051-0443(07)61787-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
125 Grasso A, Watkinson AF, Tibballs JM, Burroughs AK. Radiofrequency ablation in the treatment of hepatocellular carcinoma--a clinical viewpoint. J Hepatol. 2000;33:667-672. [PMID: 11059876 DOI: 10.1016/s0168-8278(00)80023-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
126 Tamaki K, Shimizu I, Oshio A, Fukuno H, Inoue H, Tsutsui A, Shibata H, Sano N, Ito S. Influence of large intrahepatic blood vessels on the gross and histological characteristics of lesions produced by radiofrequency ablation in a pig liver model. Liver Int 2004;24:696-701. [DOI: 10.1111/j.1478-3231.2004.0952.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
127 Hong SN, Lee SY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Rhee JC, Choi D, Lim HK, Lee KW, Joh JW. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol. 2005;39:247-252. [PMID: 15718869 DOI: 10.1097/01.mcg.0000152746.72149.31] [Cited by in Crossref: 181] [Cited by in F6Publishing: 159] [Article Influence: 11.3] [Reference Citation Analysis]
128 Ritz JP, Lehmann KS, Schumann T, Knappe V, Zurbuchen U, Buhr HJ, Holmer C. Effectiveness of various thermal ablation techniques for the treatment of nodular thyroid disease--comparison of laser-induced thermotherapy and bipolar radiofrequency ablation. Lasers Med Sci 2011;26:545-52. [PMID: 21455786 DOI: 10.1007/s10103-011-0907-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
129 Nikfarjam M, Christophi C. Interstitial laser thermotherapy for liver tumours. British Journal of Surgery 2003;90:1033-47. [DOI: 10.1002/bjs.4326] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
130 Bilchik AJ, Wood TF, Allegra DP. Radiofrequency ablation of unresectable hepatic malignancies: lessons learned. Oncologist 2001;6:24-33. [PMID: 11161226 DOI: 10.1634/theoncologist.6-1-24] [Cited by in Crossref: 82] [Cited by in F6Publishing: 65] [Article Influence: 4.1] [Reference Citation Analysis]
131 Poulou LS, Ziakas PD, Ziogas DC, Doxani C, Xyla V, Vakrinos G, Voulgarelis M, Thanos L. FDG-PET for detecting local tumor recurrence of ablated liver metastases: a diagnostic meta-analysis. Biomarkers 2012;17:532-8. [DOI: 10.3109/1354750x.2012.699553] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
132 Rendon RA, Gertner MR, Sherar MD, Asch MR, Kachura JR, Sweet J, Jewett MAS. DEVELOPMENT OF A RADIOFREQUENCY BASED THERMAL THERAPY TECHNIQUE IN AN IN VIVO PORCINE MODEL FOR THE TREATMENT OF SMALL RENAL MASSES: . THE JOURNAL OF UROLOGY. [DOI: 10.1097/00005392-200107000-00086] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
133 Chan ACY, Poon RTP, Ng KKC, Lo CM, Fan ST, Wong J. Changing Paradigm in the Management of Hepatocellular Carcinoma Improves the Survival Benefit of Early Detection by Screening. Annals of Surgery 2008;247:666-73. [DOI: 10.1097/sla.0b013e31816a747a] [Cited by in Crossref: 68] [Cited by in F6Publishing: 16] [Article Influence: 5.2] [Reference Citation Analysis]
134 Passera K, Selvaggi S, Scaramuzza D, Garbagnati F, Vergnaghi D, Mainardi L. Radiofrequency ablation of liver tumors: quantitative assessment of tumor coverage through CT image processing. BMC Med Imaging. 2013;13:3. [PMID: 23324557 DOI: 10.1186/1471-2342-13-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
135 Takahashi H, Mizuta T, Kawazoe S, Eguchi Y, Kawaguchi Y, Otuka T, Oeda S, Ario K, Iwane S, Akiyama T, Ozaki I, Fujimoto K. Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients: RFA for elderly HCC patients. Hepatology Research 2010;40:997-1005. [DOI: 10.1111/j.1872-034x.2010.00713.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
136 Sugimoto K, Moriyasu F, Shiraishi J, Yamada M, Imai Y. A phantom study comparing ultrasound-guided liver tumor puncture using new real-time 3D ultrasound and conventional 2D ultrasound. AJR Am J Roentgenol 2011;196:W753-7. [PMID: 21606264 DOI: 10.2214/AJR.10.5552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
137 Scaife CL, Curley SA. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am. 2003;12:243-255. [PMID: 12735142 DOI: 10.1016/s1055-3207(02)00088-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
138 Bolondi L, Gaiani S, Celli N, Piscaglia F. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:608; author reply 610-1. [PMID: 11526551 DOI: 10.1002/hep.510340325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 0.1] [Reference Citation Analysis]
139 Chen MS, Peng ZW, Xu L, Zhang YJ, Liang HH, Li JQ. Role of radiofrequency ablation in the treatment of hepatocellular carcinoma: experience of a cancer center in China. Oncology. 2011;81 Suppl 1:100-104. [PMID: 22212942 DOI: 10.1159/000333268] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
140 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: a literature review. Int J Hepatol. 2011;2011:104685. [PMID: 21994847 DOI: 10.4061/2011/104685] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
141 Shibuya A, Nakazawa T, Saigenji K, Furuta K, Matsunaga K. Diaphragmatic hernia after radiofrequency ablation therapy for hepatocellular carcinoma. AJR Am J Roentgenol. 2006;186:S241-S243. [PMID: 16632682 DOI: 10.2214/ajr.04.0931] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
142 Morimoto M, Numata K, Sugimori K, Shirato K, Kokawa A, Oka H, Hirasawa K, Koh R, Nihommatsu H, Tanaka K. Successful initial ablation therapy contributes to survival in patients with hepatocellular carcinoma. World J Gastroenterol 2007;13:1003-9. [PMID: 17373733 DOI: 10.3748/wjg.v13.i7.1003] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
143 Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol. 2006;16:661-669. [PMID: 16228211 DOI: 10.1007/s00330-005-0029-9] [Cited by in Crossref: 155] [Cited by in F6Publishing: 144] [Article Influence: 9.7] [Reference Citation Analysis]
144 Varghese T, Shi H. Elastographic Imaging of Thermal Lesions in Liver In-Vivo Using Diaphragmatic Stimuli. Ultrason Imaging 2004;26:18-28. [DOI: 10.1177/016173460402600102] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 6.6] [Reference Citation Analysis]
145 Liu LX, Jiang HC, Piao DX. Radiofrequence ablation of liver cancers. World J Gastroenterol. 2002;8:393-389. [DOI: 10.3748/wjg.v8.i3.393] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
146 Galandi D, Antes G. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. Cochrane Database Syst Rev. 2004;CD003046. [PMID: 15106188 DOI: 10.1002/14651858.cd003046.pub3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 1.8] [Reference Citation Analysis]
147 Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, De Wever I, Michel L. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89:1206-1222. [PMID: 12296886 DOI: 10.1046/j.1365-2168.2002.02168.x] [Cited by in Crossref: 529] [Cited by in F6Publishing: 419] [Article Influence: 27.8] [Reference Citation Analysis]
148 Seidenfeld J, Korn A, Aronson N. Radiofrequency ablation of unresectable liver metastases. J Am Coll Surg. 2002;195:378-386. [PMID: 12229947 DOI: 10.1016/S1072-7515(02)01247-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
149 Ahmed M, Goldberg SN. Thermal ablation therapy for hepatocellular carcinoma. J Vasc Interv Radiol 2002;13:S231-44. [PMID: 12354841 DOI: 10.1016/s1051-0443(07)61791-6] [Cited by in Crossref: 69] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
150 Lee FT, Chosy SG, Littrup PJ, Warner TF, Kuhlman JE, Mahvi DM. CT-monitored Percutaneous Cryoablation in a Pig Liver Model: Pilot Study. Radiology 1999;211:687-92. [DOI: 10.1148/radiology.211.3.r99jn29687] [Cited by in Crossref: 82] [Cited by in F6Publishing: 68] [Article Influence: 3.7] [Reference Citation Analysis]
151 Giorgio A, Tarantino L, de Stefano G, Scala V, Liorre G, Scarano F, Perrotta A, Farella N, Aloisio V, Mariniello N, Coppola C, Francica G, Ferraioli G. Percutaneous Sonographically Guided Saline-Enhanced Radiofrequency Ablation of Hepatocellular Carcinoma. American Journal of Roentgenology 2003;181:479-84. [DOI: 10.2214/ajr.181.2.1810479] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
152 Lorentzen T, Christensen NE, Nolsle CP, Torp-Pedersen ST. Radiofrequency tissue ablation with a cooled needle in vitro: ultrasonography, dose response, and lesion temperature. Acad Radiol. 1997;4:292-297. [PMID: 9110027 DOI: 10.1016/S1076-6332(97)80031-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
153 Chung Y, Duerk JL, Lewin JS. Generation and Observation of Radio Frequency Thermal Lesion Ablation for Interventional Magnetic Resonance Imaging: . INVESTIGATIVE RADIOLOGY 1997;32:466-74. [DOI: 10.1097/00004424-199708000-00006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
154 Fang Y, Chen W, Liang X, Li D, Lou H, Chen R, Wang K, Pan H. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma. J Gastroenterol Hepatol. 2014;29:193-200. [PMID: 24224779 DOI: 10.1111/jgh.12441] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 10.4] [Reference Citation Analysis]
155 Goldberg SN, Ahmed M. Minimally invasive image-guided therapies for hepatocellular carcinoma. J Clin Gastroenterol 2002;35:S115-29. [PMID: 12394215 DOI: 10.1097/00004836-200211002-00008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
156 Li M, Yu XL, Liang P, Liu F, Dong B, Zhou P. Percutaneous microwave ablation for liver cancer adjacent to the diaphragm. Int J Hyperthermia 2012;28:218-26. [PMID: 22515343 DOI: 10.3109/02656736.2012.665565] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
157 Tateishi R, Shiina S, Yoshida H, Teratani T, Obi S, Yamashiki N, Yoshida H, Akamatsu M, Kawabe T, Omata M. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 2006;44:1518-27. [DOI: 10.1002/hep.21408] [Cited by in Crossref: 105] [Cited by in F6Publishing: 94] [Article Influence: 7.0] [Reference Citation Analysis]
158 Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002;235:466-86. [PMID: 11923602 DOI: 10.1097/00000658-200204000-00004] [Cited by in Crossref: 300] [Cited by in F6Publishing: 268] [Article Influence: 15.8] [Reference Citation Analysis]
159 Holm H. Interventional ultrasound in Europe. Ultrasound in Medicine & Biology 1998;24:779-91. [DOI: 10.1016/s0301-5629(98)00057-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
160 Carrafiello G, Laganà D, Ianniello A, Craparo G, Recaldini C, Lumia D, Dionigi G, Cuffari S, Fugazzola C. Bleeding after percutaneous radiofrequency ablation: Successful treatment with transcatheter embolization. Eur J Radiol. 2007;61:351-355. [PMID: 17097255 DOI: 10.1016/j.ejrad.2006.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
161 Li M, Yu X, Liang P, Dong B, Liu F. Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder. International Journal of Hyperthermia 2015;31:579-87. [DOI: 10.3109/02656736.2015.1014869] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
162 Choi JH, Ahn MJ, Rhim H, Lee HW, Oh HS, Lee YY, Choi IY, Kim IS. Radiofrequency ablation for metastatic hepatic tumor in colorectal carcinoma. Cancer Res Treat 2004;36:128-31. [PMID: 20396552 DOI: 10.4143/crt.2004.36.2.128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
163 Chopra S, Dodd GD, Chanin MP, Chintapalli KN. Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety. AJR Am J Roentgenol. 2003;180:697-701. [PMID: 12591677 DOI: 10.2214/ajr.180.3.1800697] [Cited by in Crossref: 90] [Cited by in F6Publishing: 66] [Article Influence: 5.0] [Reference Citation Analysis]
164 Koizumi Y, Hirooka M, Ochi H, Tokumoto Y, Takechi M, Hiraoka A, Ikeda Y, Kumagi T, Matsuura B, Abe M, Hiasa Y. Characterization of the biliary tract by virtual ultrasonography constructed by gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. J Med Ultrasonics 2015;42:185-93. [DOI: 10.1007/s10396-014-0598-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
165 Morimoto M, Nozawa A, Numata K, Shirato K, Sugimori K, Kokawa A, Tomita N, Saitou T, Nakatani Y, Imada T, Tanaka K. Evaluation Using Contrast-Enhanced Harmonic Gray Scale Sonography After Radio Frequency Ablation of Small Hepatocellular Carcinoma: Sonographic-Histopathologic Correlation. Journal of Ultrasound in Medicine 2005;24:273-83. [DOI: 10.7863/jum.2005.24.3.273] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
166 Solbiati L. New applications of ultrasonography: interventional ultrasound. European Journal of Radiology 1998;27:S200-6. [DOI: 10.1016/s0720-048x(98)00063-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
167 Sharr WW, Chan SC, Lo CM. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation. Transplantation. 2014;97 Suppl 8:S10-S17. [PMID: 24849822 DOI: 10.1097/01.tp.0000446267.19148.21] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
168 Friedman M, Mikityansky I, Kam A, Libutti SK, Walther MM, Neeman Z, Locklin JK, Wood BJ. Radiofrequency ablation of cancer. Cardiovasc Intervent Radiol. 2004;27:427-434. [PMID: 15383844 DOI: 10.1007/s00270-004-0062-0] [Cited by in Crossref: 58] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
169 Davies AM, Weinberg U, Palti Y. Tumor treating fields: a new frontier in cancer therapy. Ann N Y Acad Sci 2013;1291:86-95. [PMID: 23659608 DOI: 10.1111/nyas.12112] [Cited by in Crossref: 81] [Cited by in F6Publishing: 58] [Article Influence: 10.1] [Reference Citation Analysis]
170 Chen MH, Yang W, Yan K, Zou MW, Solbiati L, Liu JB, Dai Y. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process. Radiology. 2004;232:260-271. [PMID: 15166323 DOI: 10.1148/radiol.2321030821] [Cited by in Crossref: 169] [Cited by in F6Publishing: 137] [Article Influence: 9.9] [Reference Citation Analysis]
171 Choi H, Loyer EM, DuBrow RA, Kaur H, David CL, Huang S, Curley S, Charnsangavej C. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 2001;21 Spec No:S41-54. [PMID: 11598247 DOI: 10.1148/radiographics.21.suppl_1.g01oc08s41] [Cited by in Crossref: 108] [Cited by in F6Publishing: 90] [Article Influence: 5.4] [Reference Citation Analysis]
172 Patriarca C, Bergamaschi F, Gazzano G, Corrada P, Ordesi G, Zanitzer L, Di Pasquale M, Giunta P, Campo B. Histopathological findings after radiofrequency (RITA) treatment for prostate cancer. Prostate Cancer Prostatic Dis 2006;9:266-9. [DOI: 10.1038/sj.pcan.4500877] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
173 Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, Yamashiki N, Inoue K. Percutaneous Microwave Coagulation Therapy for Solitary Metastatic Liver Tumors From Colorectal Cancer: A Pilot Clinical Study. American Journal of Gastroenterology 1999;94:322-7. [DOI: 10.1111/j.1572-0241.1999.00849.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 2.4] [Reference Citation Analysis]
174 Prakash S, Karnes MP, Sequin EK, West JD, Hitchcock CL, Nichols SD, Bloomston M, Abdel-Misih SR, Schmidt CR, Martin EW Jr, Povoski SP, Subramaniam VV. Ex vivo electrical impedance measurements on excised hepatic tissue from human patients with metastatic colorectal cancer. Physiol Meas 2015;36:315-28. [PMID: 25597963 DOI: 10.1088/0967-3334/36/2/315] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
175 Nagae G, Ido K, Isoda N, Sato S, Kita H, Sugano K. LAPAROSCOPIC ABLATION THERAPY FOR HEPATOCELLULAR CARCINOMA. Dig Endosc 2005;17:1-8. [DOI: 10.1111/j.1443-1661.2005.00471.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
176 Nishikawa H, Osaki Y, Iguchi E, Takeda H, Matsuda F, Nakajima J, Sakamoto A, Hatamaru K, Saito S, Nasu A, Kita R, Kimura T. Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes. J Gastroenterol 2013;48:951-65. [PMID: 23065022 DOI: 10.1007/s00535-012-0690-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
177 Mahvi DM, Lee FT Jr. Radiofrequency ablation of hepatic malignancies: is heat better than cold? Ann Surg 1999;230:9-11. [PMID: 10400030 DOI: 10.1097/00000658-199907000-00002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
178 Parikh AA, Curley SA, Fornage BD, Ellis LM. Radiofrequency ablation of hepatic metastases. Semin Oncol 2002;29:168-82. [PMID: 11951215 DOI: 10.1053/sonc.2002.31673] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
179 Ishikawa T. Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients. World J Gastroenterol. 2008;14:6140-6144. [PMID: 18985803 DOI: 10.3748/wjg.14.6140] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
180 Cha CH, Lee FT, Gurney JM, Markhardt BK, Warner TF, Kelcz F, Mahvi DM. CT Versus Sonography for Monitoring Radiofrequency Ablation in a Porcine Liver. American Journal of Roentgenology 2000;175:705-11. [DOI: 10.2214/ajr.175.3.1750705] [Cited by in Crossref: 118] [Cited by in F6Publishing: 105] [Article Influence: 5.6] [Reference Citation Analysis]
181 Martin RC, Husheck S, Scoggins CR, McMasters KM. Intraoperative magnetic resonance imaging for ablation of hepatic tumors. Surg Endosc 2006;20:1536-42. [PMID: 16897290 DOI: 10.1007/s00464-005-0496-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
182 Okamoto E, Sato S, Sanchez-Siles AA, Ishine J, Miyake T, Amano Y, Kinoshita Y. Evaluation of virtual CT sonography for enhanced detection of small hepatic nodules: a prospective pilot study. AJR Am J Roentgenol 2010;194:1272-8. [PMID: 20410414 DOI: 10.2214/AJR.08.2294] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
183 Merkle EM, Haaga JR, Duerk JL, Jacobs GH, Brambs HJ, Lewin JS. MR imaging-guided radio-frequency thermal ablation in the pancreas in a porcine model with a modified clinical C-arm system. Radiology. 1999;213:461-467. [PMID: 10551227 DOI: 10.1148/radiology.213.2.r99nv21461] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
184 Kim SK, Lim HK, Kim YH, Lee WJ, Lee SJ, Kim SH, Lim JH, Kim SA. Hepatocellular Carcinoma Treated with Radio-frequency Ablation: Spectrum of Imaging Findings. RadioGraphics 2003;23:107-21. [DOI: 10.1148/rg.231025055] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 5.1] [Reference Citation Analysis]
185 Ishikawa T. Radiofrequency ablation is justified for elderly patients with hepatocellular carcinoma: Editorial. Hepatology Research 2010;40:954-5. [DOI: 10.1111/j.1872-034x.2010.00725.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
186 Francica G, Marone G. Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a 'cooled-tip needle'. A preliminary clinical experience. Eur J Ultrasound. 1999;9:145-153. [PMID: 10413750 DOI: 10.1016/s0929-8266(99)00022-1] [Cited by in Crossref: 85] [Cited by in F6Publishing: 16] [Article Influence: 3.9] [Reference Citation Analysis]
187 Delis S, Bramis I, Triantopoulou C, Madariaga J, Dervenis C. The imprint of radiofrequency in the management of hepatocellular carcinoma. HPB (Oxford) 2006;8:255-63. [PMID: 18333136 DOI: 10.1080/13651820500273673] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
188 Szymanski-Exner A, Stowe NT, Lazebnik RS, Salem K, Wilson DL, Haaga JR, Gao J. Noninvasive monitoring of local drug release in a rabbit radiofrequency (RF) ablation model using X-ray computed tomography. J Control Release 2002;83:415-25. [PMID: 12387949 DOI: 10.1016/s0168-3659(02)00216-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
189 Shirato K, Morimoto M, Tomita N, Kokawa A, Sugimori K, Saito T, Numata K, Sekihara H, Tanaka K. Small Hepatocellular Carcinoma: Therapeutic Effectiveness of Percutaneous Radio Frequency Ablation Therapy With a LeVeen Needle Electrode. Journal of Ultrasound in Medicine 2002;21:67-76. [DOI: 10.7863/jum.2002.21.1.67] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
190 Teague BD, Wemyss-holden SA, Fosh BG, Dennison AR, Maddern GJ. Electrolysis and other local ablative treatments for non-resectable colorectal liver metastases: NON-RESECTABLE COLORECTAL LIVER METASTASES. ANZ Journal of Surgery 2002;72:137-41. [DOI: 10.1046/j.1445-2197.2002.02326.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
191 Shetty SK, Rosen MP, Raptopoulos V, Goldberg SN. Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms. J Vasc Interv Radiol 2001;12:823-33. [PMID: 11435538 DOI: 10.1016/s1051-0443(07)61507-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
192 Murakami E, Aikata H, Miyaki D, Nagaoki Y, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Waki K, Takahashi S. Hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic interferon-α for advanced hepatocellular carcinoma in combination with or without three-dimensional conformal radiotherapy to venous tumor thrombosis in hepatic vein or inferior vena cava. Hepatol Res. 2012;42:442-453. [PMID: 22176468 DOI: 10.1111/j.1872-034x.2011.00943.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
193 Hori M, Murakami T, Kim T, Nakamura H. Diagnosis of hepatic neoplasms using CT arterial portography and CT hepatic arteriography. Techniques in Vascular and Interventional Radiology 2002;5:164-9. [DOI: 10.1053/tvir.2002.36416] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
194 Shibata T, Iimuro Y, Ikai I, Hatano E, Yamaoka Y, Konishi J. Percutaneous Radiofrequency Ablation Therapy after Intrathoracic Saline Solution Infusion for Liver Tumor in the Hepatic Dome. Journal of Vascular and Interventional Radiology 2002;13:313-5. [DOI: 10.1016/s1051-0443(07)61725-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
195 Lee JM, Han JK, Lee JY, Kim SH, Choi JY, Lee MW, Choi SH, Eo H, Choi BI. Hepatic radiofrequency ablation using multiple probes: ex vivo and in vivo comparative studies of monopolar versus multipolar modes. Korean J Radiol 2006;7:106-17. [PMID: 16799271 DOI: 10.3348/kjr.2006.7.2.106] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
196 Rust C, Gores GJ. Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies. Clin Liver Dis. 2001;5:161-173. [PMID: 11218913 DOI: 10.1016/s1089-3261(05)70159-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
197 Macchi EG, Tosi D, Braschi G, Gallati M, Cigada A, Busca G, Lewis E. Optical fiber sensors-based temperature distribution measurement in ex vivo radiofrequency ablation with submillimeter resolution. J Biomed Opt 2014;19:117004. [DOI: 10.1117/1.jbo.19.11.117004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 4.6] [Reference Citation Analysis]
198 Huang CY, Batzorig U, Cheng WL, Huang MT, Chen W, Wei PL, Chang YJ. Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma. Tumour Biol 2016;37:4295-304. [PMID: 26493996 DOI: 10.1007/s13277-015-4254-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
199 Peng ZW, Liang HH, Chen MS, Zhang YJ, Zhang YQ, Lau WY. Conformal radiofrequency ablation of hepatocellular carcinoma with a multi-pin bipolar system. J Surg Oncol. 2011;103:69-74. [PMID: 21031425 DOI: 10.1002/jso.21742] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
200 Tang Z, Fang H, Kang M, Zhang B, Dong X, Chen X, Xu J, Chen J, Wu Y. Percutaneous radiofrequency ablation for liver tumors: Is it safer and more effective in low-risk areas than in high-risk areas? Hepatol Res 2011;41:635-40. [PMID: 21711422 DOI: 10.1111/j.1872-034X.2011.00817.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
201 Cha C, DeMatteo RP, Blumgart LH. Surgery and ablative therapy for hepatocellular carcinoma. J Clin Gastroenterol. 2002;35:S130-S137. [PMID: 12449982 DOI: 10.1097/00004836-200211002-00009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
202 Machi J, Bueno RS, Wong LL. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg. 2005;29:1364-1373. [PMID: 16240062 DOI: 10.1007/s00268-005-7829-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
203 Rhim H, Yoon KH, Lee JM, Cho Y, Cho JS, Kim SH, Lee WJ, Lim HK, Nam GJ, Han SS, Kim YH, Park CM, Kim PN, Byun JY. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics. 2003;23:123-34; discussion 134-6. [PMID: 12533647 DOI: 10.1148/rg.231025054] [Cited by in Crossref: 249] [Cited by in F6Publishing: 191] [Article Influence: 13.8] [Reference Citation Analysis]
204 Lu DS, Raman SS, Limanond P, Aziz D, Economou J, Busuttil R, Sayre J. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol. 2003;14:1267-1274. [PMID: 14551273 DOI: 10.1097/01.rvi.0000092666.72261.6b] [Cited by in Crossref: 318] [Cited by in F6Publishing: 109] [Article Influence: 18.7] [Reference Citation Analysis]
205 Liapi E, Geschwind JF. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol. 2007;25:978-986. [PMID: 17350947 DOI: 10.1200/jco.2006.09.8657] [Cited by in Crossref: 129] [Cited by in F6Publishing: 49] [Article Influence: 9.2] [Reference Citation Analysis]
206 Wong SH, Watkins RD, Kupnik M, Pauly KB, Khuri-Yakub BT. Feasibility of MR-temperature mapping of ultrasonic heating from a CMUT. IEEE Trans Ultrason Ferroelectr Freq Control 2008;55:811-8. [PMID: 18467225 DOI: 10.1109/TUFFC.2008.715] [Cited by in Crossref: 33] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
207 Varghese T, Daniels M. Real-Time Calibration of Temperature Estimates during Radiofrequency Ablation. Ultrason Imaging 2004;26:185-200. [DOI: 10.1177/016173460402600305] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 4.4] [Reference Citation Analysis]
208 Hansen PD, Cassera MA, Wolf RF. Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver. Surg Oncol Clin N Am 2015;24:97-119. [PMID: 25444471 DOI: 10.1016/j.soc.2014.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
209 Ni Y, Mulier S, Miao Y, Michel L, Marchal G. A review of the general aspects of radiofrequency ablation. Abdom Imaging. 2005;30:381-400. [PMID: 15776302 DOI: 10.1007/s00261-004-0253-9] [Cited by in Crossref: 141] [Cited by in F6Publishing: 87] [Article Influence: 8.8] [Reference Citation Analysis]
210 Lucey BC, Maher MM, Gervais DA, Mueller PR. Bacterial peritonitis: a postulated cause of death associated with hepatic radiofrequency ablation. Clin Radiol 2002;57:765-7. [PMID: 12169291 DOI: 10.1053/crad.2002.0975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
211 Adachi A, Kaminou T, Ogawa T, Kawai T, Takaki Y, Sugiura K, Ohuchi Y, Hashimoto M. Heat distribution in the spinal canal during radiofrequency ablation for vertebral lesions: study in swine. Radiology 2008;247:374-80. [PMID: 18430872 DOI: 10.1148/radiol.2472070808] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
212 Katamura Y, Aikata H, Kimura Y, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Ishikawa M, Hieda M, Kakizawa H, Chayama K. Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases: Chemotherapy for hepatoma. Journal of Gastroenterology and Hepatology 2010;25:1117-22. [DOI: 10.1111/j.1440-1746.2009.06110.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
213 Sakr AA, Saleh AA, Moeaty AA, Moeaty AA. The combined effect of radiofrequency and ethanol ablation in the management of large hepatocellular carcinoma. Eur J Radiol 2005;54:418-25. [PMID: 15899345 DOI: 10.1016/j.ejrad.2004.06.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
214 Chiou SY, Liu JB, Needleman L. Current status of sonographically guided radiofrequency ablation techniques. J Ultrasound Med 2007;26:487-99. [PMID: 17384046 DOI: 10.7863/jum.2007.26.4.487] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
215 Georgiades CS, Ramsey DE, Solomon S, Geschwind JH. New nonsurgical therapies in the treatment of hepatocellular carcinoma. Techniques in Vascular and Interventional Radiology 2001;4:193-9. [DOI: 10.1016/s1089-2516(01)90025-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
216 Lee HY, Rhim H, Lee MW, Kim YS, Choi D, Park MJ, Kim YK, Kim SH, Lim HK. Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors. Eur Radiol. 2013;23:190-197. [PMID: 23085860 DOI: 10.1007/s00330-012-2561-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
217 Buscarini L, Buscarini E. Radiofrequency Thermal Ablation of Hepatocellular Carcinoma. In: Habib NA, editor. Multi-Treatment Modalities of Liver Tumours. Boston: Springer US; 2002. pp. 119-29. [DOI: 10.1007/978-1-4615-0547-1_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
218 Xie H, Wang H, An W, Ma W, Qi R, Yang B, Liu C, Gao Y, Xu B, Wang W. The efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization for primary hepatocellular carcinoma in a cohort of 487 patients. PLoS One. 2014;9:e89081. [PMID: 24586515 DOI: 10.1371/journal.pone.0089081] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
219 Lee JM, Lee YH, Kim YK, Kim SW, Kim SH, Han JK, Choi BI. Combined treatment of radiofrequency ablation and acetic acid injection: an in vivo feasibility study in rabbit liver. Eur Radiol. 2004;14:1303-1310. [PMID: 14625783 DOI: 10.1007/s00330-003-2140-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
220 Helmberger T, Dogan S, Straub G, Schrader A, Jüngst C, Reiser M, Waggershauser T, Jakobs T, Hoffmann R, Löhe F, Graeb C, Rau H, Schauer R, Jauch K, Caselmann WH, Göke B, Jüngst D. Liver Resection or Combined Chemoembolization and Radiofrequency Ablation Improve Survival in Patients with Hepatocellular Carcinoma. Digestion 2007;75:104-12. [DOI: 10.1159/000104730] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
221 Martin RC. Intraoperative magnetic resonance imaging ablation of hepatic tumors. The American Journal of Surgery 2005;189:388-94. [DOI: 10.1016/j.amjsurg.2005.01.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
222 Tanigawa N, Arai Y, Yamakado K, Aramaki T, Inaba Y, Kanazawa S, Matsui O, Miyazaki M, Kodama Y, Anai H, Hamanaka A. Phase I/II Study of Radiofrequency Ablation for Painful Bone Metastases: Japan Interventional Radiology in Oncology Study Group 0208. Cardiovasc Intervent Radiol 2018;41:1043-8. [PMID: 29675772 DOI: 10.1007/s00270-018-1944-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
223 Rai R, Manas D. Radiofrequency ablation of unresectable liver tumours. Hosp Med 2003;64:737-9. [PMID: 14702787 DOI: 10.12968/hosp.2003.64.12.2367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
224 Miao Y, Ni Y, Yu J, Marchal G. A comparative study on validation of a novel cooled-wet electrode for radiofrequency liver ablation. Invest Radiol. 2000;35:438-444. [PMID: 10901106 DOI: 10.1097/00004424-200007000-00007] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 3.3] [Reference Citation Analysis]
225 Thandassery RB, Goenka U, Goenka MK. Role of local ablative therapy for hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4:S104-S111. [PMID: 25755601 DOI: 10.1016/j.jceh.2014.03.046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
226 Kuruppu D, Christophi C, Maeda H, O'brien PE. Changes in the Microvascular Architecture of Colorectal Liver Metastases Following the Administration of SMANCS/Lipiodol. Journal of Surgical Research 2002;103:47-54. [DOI: 10.1006/jsre.2001.6299] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
227 Aschoff AJ, Merkle EM, Wong V, Zhang Q, Mendez MM, Duerk JL, Lewin JS. How does alteration of hepatic blood flow affect liver perfusion and radiofrequency-induced thermal lesion size in rabbit liver? J Magn Reson Imaging 2001;13:57-63. [DOI: 10.1002/1522-2586(200101)13:1<57::aid-jmri1009>3.0.co;2-n] [Cited by in Crossref: 46] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
228 Best J, Schotten C, Theysohn JM, Wetter A, Müller S, Radünz S, Schulze M, Canbay A, Dechêne A, Gerken G. Novel implications in the treatment of hepatocellular carcinoma. Ann Gastroenterol 2017;30:23-32. [PMID: 28042235 DOI: 10.20524/aog.2016.0092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
229 Machi J, Uchida S, Sumida K, Limm WM, Hundahl SA, Oishi AJ, Furumoto NL, Oishi RH. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J Gastrointest Surg 2001;5:477-89. [PMID: 11985998 DOI: 10.1016/s1091-255x(01)80085-8] [Cited by in Crossref: 156] [Cited by in F6Publishing: 49] [Article Influence: 8.2] [Reference Citation Analysis]
230 Dromain C, de Baere T, Elias D, Kuoch V, Ducreux M, Boige V, Petrow P, Roche A, Sigal R. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002;223:255-262. [PMID: 11930075 DOI: 10.1148/radiol.2231010780] [Cited by in Crossref: 243] [Cited by in F6Publishing: 190] [Article Influence: 12.8] [Reference Citation Analysis]
231 Goto E, Tateishi R, Shiina S, Masuzaki R, Enooku K, Sato T, Ohki T, Kondo Y, Goto T, Yoshida H. Hemorrhagic complications of percutaneous radiofrequency ablation for liver tumors. J Clin Gastroenterol. 2010;44:374-380. [PMID: 19809357 DOI: 10.1097/mcg.0b013e3181b7ed76] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
232 Cerwenka H, Bacher H, Mischinger H. Primary hepatoma – guidelines for interdisciplinary treatment. Eur Surg 2006;38:94-9. [DOI: 10.1007/s10353-006-0227-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
233 Murakami T, Ishimaru H, Sakamoto I, Uetani M, Matsuoka Y, Daikoku M, Honda S, Koshiishi T, Fujimoto T. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence. Cardiovasc Intervent Radiol. 2007;30:696-704. [PMID: 17497071 DOI: 10.1007/s00270-007-9003-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
234 Rose SC, Hassanein TI, Easter DW, Gamagami RA, Bouvet M, Pretorius DH, Nelson TR, Kinney TB, James GM. Value of Three-dimensional US for Optimizing Guidance for Ablating Focal Liver Tumors. Journal of Vascular and Interventional Radiology 2001;12:507-15. [DOI: 10.1016/s1051-0443(07)61892-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
235 Shirai K, Tamai H, Shingaki N, Mori Y, Moribata K, Enomoto S, Deguchi H, Ueda K, Maekita T, Inoue I, Iguchi M, Yanaoka K, Oka M, Ichinose M. Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma: Seeding after RFA for HCC. Hepatology Research 2011;41:738-45. [DOI: 10.1111/j.1872-034x.2011.00841.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
236 Orlacchio A, Bazzocchi G, Pastorelli D, Bolacchi F, Angelico M, Almerighi C, Masala S, Simonetti G. Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience. Cardiovasc Intervent Radiol. 2008;31:587-594. [PMID: 18236104 DOI: 10.1007/s00270-008-9293-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
237 Ng KK, Poon RT, Lo C, Yuen J, Tso WK, Fan S. Analysis of Recurrence Pattern and Its Influence on Survival Outcome After Radiofrequency Ablation of Hepatocellular Carcinoma. J Gastrointest Surg 2008;12:183-91. [DOI: 10.1007/s11605-007-0276-y] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 8.2] [Reference Citation Analysis]
238 McGhana JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol. 2001;176:3-16. [PMID: 11133529 DOI: 10.2214/ajr.176.1.1760003] [Cited by in Crossref: 460] [Cited by in F6Publishing: 353] [Article Influence: 23.0] [Reference Citation Analysis]
239 Nakai M, Sato M, Sahara S, Takasaka I, Kawai N, Minamiguchi H, Tanihata H, Kimura M, Takeuchi N. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography. Cardiovasc Intervent Radiol 2009;32:62-9. [PMID: 18987911 DOI: 10.1007/s00270-008-9462-x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
240 Jaskolka JD, Asch MR, Kachura JR, Ho CS, Ossip M, Wong F, Sherman M, Grant DR, Greig PD, Gallinger S. Needle Tract Seeding after Radiofrequency Ablation of Hepatic Tumors. Journal of Vascular and Interventional Radiology 2005;16:485-91. [DOI: 10.1097/01.rvi.0000151141.09597.5f] [Cited by in Crossref: 109] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
241 Moghbel M, Mashohor S, Mahmud R, Saripan MI. Automatic liver tumor segmentation on computed tomography for patient treatment planning and monitoring. EXCLI J 2016;15:406-23. [PMID: 27540353 DOI: 10.17179/excli2016-402] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
242 Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, Matsuyama Y, Okazaki M, Okita K, Omata M. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008;38:37-51. [PMID: 18039202 DOI: 10.1111/j.1872-034x.2007.00216.x] [Cited by in Crossref: 211] [Cited by in F6Publishing: 78] [Article Influence: 21.1] [Reference Citation Analysis]
243 Zhang B, Moser M, Zhang E, Zhang WJ. Radiofrequency ablation technique in the treatment of liver tumours: review and future issues. J Med Eng Technol. 2013;37:150-159. [PMID: 23360198 DOI: 10.3109/03091902.2012.754510] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
244 Akahane M, Koga H, Kato N, Yamada H, Uozumi K, Tateishi R, Teratani T, Shiina S, Ohtomo K. Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics. 2005;25 Suppl 1:S57-S68. [PMID: 16227497 DOI: 10.1148/rg.25si055505] [Cited by in Crossref: 110] [Cited by in F6Publishing: 85] [Article Influence: 7.3] [Reference Citation Analysis]
245 Arata MA, Nisenbaum HL, Clark TW, Soulen MC. Percutaneous Radiofrequency Ablation of Liver Tumors with the LeVeen Probe: Is Roll-off Predictive of Response? Journal of Vascular and Interventional Radiology 2001;12:455-8. [DOI: 10.1016/s1051-0443(07)61884-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
246 Llovet JM, Vilana R, Bianchi L, Brú C. [Radiofrequency in the treatment of hepatocellular carcinoma]. Gastroenterol Hepatol 2001;24:303-11. [PMID: 11459568 DOI: 10.1016/s0210-5705(01)70180-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
247 Galandi D, Antes G, Galandi D. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd003046.pub2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
248 Okuma T, Okamura T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, Koyama K, Inoue K, Nakamura K, Inoue Y. Fluorine- 18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: Preliminary results. Ann Nucl Med 2006;20:115-21. [DOI: 10.1007/bf02985623] [Cited by in Crossref: 57] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
249 Hanna NN. Radiofrequency ablation of primary and metastatic hepatic malignancies. Clin Colorectal Cancer 2004;4:92-100. [PMID: 15285816 DOI: 10.3816/ccc.2004.n.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
250 Noguchi O, Izumi N, Inoue K, Nishimura Y, Ueda K, Tsuchiya K, Hamano K, Itakura J, Asahina Y, Uchihara M, Miyake S. Laparoscopic ablation therapy for hepatocellular carcinoma. Clinical significance of a newly developed laparoscopic sector ultrasonic probe. Dig Endosc 2003;15:179-84. [DOI: 10.1046/j.1443-1661.2003.00241.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
251 Chopra S, Dodd GD, Chintapalli KN, Leyendecker JR, Karahan OI, Rhim H. Tumor Recurrence After Radiofrequency Thermal Ablation of Hepatic Tumors: Spectrum of Findings on Dual-Phase Contrast-Enhanced CT. American Journal of Roentgenology 2001;177:381-7. [DOI: 10.2214/ajr.177.2.1770381] [Cited by in Crossref: 106] [Cited by in F6Publishing: 81] [Article Influence: 5.3] [Reference Citation Analysis]
252 Thompson DM, Arregui ME. Role of laparoscopic ultrasound in cancer management. Semin Surg Oncol 1998;15:166-75. [DOI: 10.1002/(sici)1098-2388(199810/11)15:3<166::aid-ssu5>3.0.co;2-9] [Cited by in Crossref: 11] [Article Influence: 0.5] [Reference Citation Analysis]
253 Liu LX, Zhang WH, Jiang HC. Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 2003;9:193-200. [PMID: 12532430 DOI: 10.3748/wjg.v9.i2.193] [Cited by in CrossRef: 93] [Cited by in F6Publishing: 84] [Article Influence: 5.2] [Reference Citation Analysis]
254 Nakai M, Sato M, Sahara S, Kawai N, Tanihata H, Kimura M, Terada M. Radiofrequency ablation in a porcine liver model: effects of transcatheter arterial embolization with iodized oil on ablation time, maximum output, and coagulation diameter as well as angiographic characteristics. World J Gastroenterol 2007;13:2841-5. [PMID: 17569120 DOI: 10.3748/wjg.v13.i20.2841] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
255 Alsowmely AM, Hodgson HJ. Non-surgical treatment of hepatocellular carcinoma. Aliment Pharmacol Ther. 2002;16:1-15. [PMID: 11856073 DOI: 10.1046/j.1365-2036.2002.01149.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
256 Liu Y, Li H, Matsui O. The antiangiogenic effect of thalidomide on occult liver metastases: An in vivo study in mice. Journal of Gastroenterology and Hepatology 2009;24:1077-81. [DOI: 10.1111/j.1440-1746.2008.05748.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
257 Sakaguchi H, Seki S, Tsuji K, Teramoto K, Suzuki M, Kioka K, Isoda N, Ido K. Endoscopic thermal ablation therapies for hepatocellular carcinoma: a multi-center study. Hepatol Res. 2009;39:47-52. [PMID: 18761680 DOI: 10.1111/j.1872-034x.2008.00410.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
258 Strasberg SM, Linehan D. Radiofrequency ablation of liver tumors. Curr Probl Surg. 2003;40:459-498. [PMID: 12865889 DOI: 10.1016/s0011-3840(03)00050-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
259 Bruenn K, Beyer L, Haimerl M, Pregler B, Stroszczynski C, Jung E, Wiggermann P, Jünger M, Krüger-genge A, Jung F. Comparison of computed tomography (CT) and contrast-enhanced ultrasound (CEUS) for the quantitative evaluation of an ablation defect following radiofrequency ablation of malignant liver lesions. CH 2017;67:445-51. [DOI: 10.3233/ch-179225] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
260 Ogihara M, Wong LL, Machi J. Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomes. HPB (Oxford). 2005;7:214-221. [PMID: 18333193 DOI: 10.1080/13651820510028846] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
261 Masuzaki R, Shiina S, Tateishi R, Yoshida H, Goto E, Sugioka Y, Kondo Y, Goto T, Ikeda H, Omata M, Koike K. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol Hepatol. 2011;26:759-764. [PMID: 21054516 DOI: 10.1111/j.1440-1746.2010.06559.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
262 Kondo M, Morimoto M, Numata K, Nozaki A, Tanaka K. Hepatic arterial infusion therapy with a fine powder formulation of cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Jpn J Clin Oncol. 2011;41:69-75. [PMID: 20688778 DOI: 10.1093/jjco/hyq145] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
263 Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, Tso WK, Fan ST, Poon RT. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors. Ann Surg Oncol. 2008;15:782-790. [PMID: 18095030 DOI: 10.1245/s10434-007-9733-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
264 Fukuda H, Ito R, Ohto M, Sakamoto A, Otsuka M, Togawa A, Miyazaki M, Yamagata H. US-CT 3D dual imaging by mutual display of the same sections for depicting minor changes in hepatocellular carcinoma. European Journal of Radiology 2012;81:2014-9. [DOI: 10.1016/j.ejrad.2011.05.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
265 Kenny LM, Orsi F, Adam A. Interventional radiology in breast cancer. Breast 2017;35:98-103. [PMID: 28704698 DOI: 10.1016/j.breast.2017.06.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
266 Buscarini E, Buscarini L. Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report. Eur Radiol. 2004;14:31-37. [PMID: 14564470 DOI: 10.1007/s00330-003-1990-9] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
267 Uña E, Trueba J, Montes JM. Unexplained liver laceration after metastasis radiofrequency ablation. World J Gastroenterol 2009;15:5103-5. [PMID: 19860006 DOI: 10.3748/wjg.15.5103] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
268 Mutsaerts E, Van Coevorden F, Krause R, Borel Rinkes I, Strobbe L, Prevoo W, Tollenaar R, Van Gulik T. Initial experience with radiofrequency ablation for hepatic tumours in the Netherlands. European Journal of Surgical Oncology (EJSO) 2003;29:731-4. [DOI: 10.1016/s0748-7983(03)00146-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
269 Vogl TJ, Farshid P, Naguib NN, Zangos S, Bodelle B, Paul J, Mbalisike EC, Beeres M, Nour-Eldin NE. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation. Abdom Imaging. 2015;40:1829-1837. [PMID: 25601438 DOI: 10.1007/s00261-015-0355-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
270 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol. 2010;2:417-424. [PMID: 21179308 DOI: 10.4329/wjr.v2.ill.417] [Reference Citation Analysis]
271 Benoist S, Nordlinger B. Radiofrequency ablation in liver tumours. Annals of Oncology 2004;15:iv313-7. [DOI: 10.1093/annonc/mdh945] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
272 Kawaguchi Y, Hasegawa K, Saiura A, Nagata R, Takahashi M, Oba M, Kaneko J, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M, Kokudo N. Surgical resection for local recurrence after radiofrequency ablation for colorectal liver metastasis is more extensive than primary resection. Scand J Gastroenterol 2014;49:569-75. [PMID: 24625240 DOI: 10.3109/00365521.2014.893013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
273 Kariya Z, Yamakado K, Nakatuka A, Onoda M, Kobayasi S, Takeda K. Radiofrequency Ablation with and without Balloon Occlusion of the Renal Artery: An Experimental Study in Porcine Kidneys. Journal of Vascular and Interventional Radiology 2003;14:241-5. [DOI: 10.1097/01.rvi.0000058327.82956.f1] [Cited by in Crossref: 25] [Article Influence: 1.4] [Reference Citation Analysis]
274 Thanos L, Poulou LS, Mailli L, Pomoni M, Kelekis DA. Image-Guided Radiofrequency Ablation of a Pancreatic Tumor with a New Triple Spiral-Shaped Electrode. Cardiovasc Intervent Radiol 2010;33:215-8. [DOI: 10.1007/s00270-009-9548-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
275 Goldberg SN, Hahn PF, Tanabe KK, Mueller PR, Schima W, Athanasoulis CA, Compton CC, Solbiati L, Gazelle GS. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol. 1998;9:101-111. [PMID: 9468403 DOI: 10.1016/s1051-0443(98)70491-9] [Cited by in Crossref: 419] [Cited by in F6Publishing: 77] [Article Influence: 18.2] [Reference Citation Analysis]
276 Ahrar K, Gowda A, Javadi S, Borne A, Fox M, McNichols R, Ahrar JU, Stephens C, Stafford RJ. Preclinical assessment of a 980-nm diode laser ablation system in a large animal tumor model. J Vasc Interv Radiol. 2010;21:555-561. [PMID: 20346883 DOI: 10.1016/j.jvir.2010.01.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
277 Lee JM, Kim SW, Li CA, Youk JH, Kim YK, Jin Z, Chung MJ, Lee MS. Saline-enhanced radiofrequency thermal ablation of the lung: a feasibility study in rabbits. Korean J Radiol 2002;3:245-53. [PMID: 12514342 DOI: 10.3348/kjr.2002.3.4.245] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
278 Cormier J, Thomas K, Chari R, Pinson C. Management of Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2006;10:761-80. [DOI: 10.1016/j.gassur.2005.10.006] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 4.0] [Reference Citation Analysis]
279 Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Sugimori N, Igarashi S, Nakashima Y, Notsumata K, Toya D, Tanaka N. Chemoembolization for the treatment of large hepatocellular carcinoma. J Vasc Interv Radiol. 2010;21:1226-1234. [PMID: 20598571 DOI: 10.1016/j.jvir.2010.04.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
280 Kamada K, Kitamoto M, Aikata H, Kawakami Y, Kono H, Imamura M, Nakanishi T, Chayama K. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma. Am J Surg. 2002;184:284-290. [PMID: 12354601 DOI: 10.1016/s0002-9610(02)00933-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
281 Trübenbach J, Pereira PL, Schick F, Claussen CD, Huppert PE. MRI-guided radiofrequency ablation of liver tumours: A valuable and minimally-invasive therapeutic option. Minimally Invasive Therapy & Allied Technologies 2009;7:533-9. [DOI: 10.3109/13645709809152900] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
282 Mazzanti R, Gramantieri L, Bolondi L. Hepatocellular carcinoma: epidemiology and clinical aspects. Mol Aspects Med. 2008;29:130-143. [PMID: 18061252 DOI: 10.1016/j.mam.2007.09.008] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 4.7] [Reference Citation Analysis]
283 Chiou Y, Hwang J, Chou Y, Wang J, Chiang J, Chang C. Percutaneous Radiofrequency Ablation of Renal Cell Carcinoma. Journal of the Chinese Medical Association 2005;68:221-5. [DOI: 10.1016/s1726-4901(09)70211-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
284 Czymek R, Nassrallah J, Gebhard M, Schmidt A, Limmer S, Kleemann M, Bruch H, Hildebrand P. Intrahepatic radiofrequency ablation versus electrochemical treatment in vivo. Surgical Oncology 2012;21:79-86. [DOI: 10.1016/j.suronc.2010.10.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
285 Ueno M, Hayami S, Shigekawa Y, Kawai M, Hirono S, Okada K, Tamai H, Shingaki N, Mori Y, Ichinose M, Yamaue H. Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: Cohort study based on serum HCC markers. Journal of Hepatology 2015;63:1352-9. [DOI: 10.1016/j.jhep.2015.07.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
286 Salama IA, Korayem E, ElAbd O, El-Refaie A. Laparoscopic ultrasound with radiofrequency ablation of hepatic tumors in cirrhotic patients. J Laparoendosc Adv Surg Tech A 2010;20:39-46. [PMID: 20100059 DOI: 10.1089/lap.2009.0208] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
287 Cioni D, Lencioni R, Rossi S, Garbagnati F, Donati F, Crocetti L, Bartolozzi C. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. AJR Am J Roentgenol. 2001;177:783-788. [PMID: 11566673 DOI: 10.2214/ajr.177.4.1770783] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 3.3] [Reference Citation Analysis]
288 Moghbel M, Mashohor S, Mahmud R, Saripan MIB. Review of liver segmentation and computer assisted detection/diagnosis methods in computed tomography. Artif Intell Rev 2018;50:497-537. [DOI: 10.1007/s10462-017-9550-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 2] [Article Influence: 10.0] [Reference Citation Analysis]
289 Rossi S, Garbagnati F, Lencioni R, Allgaier HP, Marchianò A, Fornari F, Quaretti P, Tolla GD, Ambrosi C, Mazzaferro V. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology. 2000;217:119-126. [PMID: 11012432 DOI: 10.1148/radiology.217.1.r00se02119] [Cited by in Crossref: 365] [Cited by in F6Publishing: 309] [Article Influence: 17.4] [Reference Citation Analysis]
290 Loewe C, Cejna M, Schoder M, Thurnher MM, Lammer J, Thurnher SA. Arterial embolization of unresectable hepatocellular carcinoma with use of cyanoacrylate and lipiodol. J Vasc Interv Radiol. 2002;13:61-69. [PMID: 11788696 DOI: 10.1016/s1051-0443(07)60010-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
291 Ruers T, de Jong K, Ijzermans J. Radiofrequency for the Treatment of Liver Tumours. Dig Surg 2005;22:245-53. [DOI: 10.1159/000088054] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
292 Fiorentini G, Poddie DB, De Giorgi U, Guglielminetti D, Giovanis P, Leoni M, Latino W, Dazzi C, Cariello A, Turci D, Marangolo M. Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments. Med Oncol 2000;17:163-73. [PMID: 10962525 DOI: 10.1007/BF02780523] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
293 Puneet P, Perera MTPR, Mirza DF. Current opinion on the role of resection and liver transplantation for hepatocellular cancer. Indian J Gastroenterol 2012;31:89-99. [DOI: 10.1007/s12664-012-0200-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
294 Molinari M, Helton S. Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: a Markov model decision analysis. Am J Surg. 2009;198:396-406. [PMID: 19520354 DOI: 10.1016/j.amjsurg.2009.01.016] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
295 Lee EJ, Rhim H, Lim HK, Choi D, Lee WJ, Min KS. Effect of artificial ascites on thermal injury to the diaphragm and stomach in radiofrequency ablation of the liver: experimental study with a porcine model. AJR Am J Roentgenol 2008;190:1659-64. [PMID: 18492921 DOI: 10.2214/AJR.07.2993] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
296 Veit P, Kuehle C, Beyer T, Kuehl H, Bockisch A, Antoch G. Accuracy of combined PET/CT in image-guided interventions of liver lesions: an ex-vivo study. World J Gastroenterol 2006;12:2388-93. [PMID: 16688830 DOI: 10.3748/wjg.v12.i15.2388] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
297 Zhang F, Wu G, Sun H, Ding J, Xia F, Li X, Ma K, Wang S, Bie P. Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria: a single centre with 13 years experience. Int J Hyperthermia 2014;30:471-9. [PMID: 25314335 DOI: 10.3109/02656736.2014.961042] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
298 Tang C, Feng W, Qin L, Bao Y. Chinese Herbal Medicine, Jian Pi Li Gan Decoction, Improved Survival of Nonresectable Hepatocellular Cancer After Radiofrequency Ablation: A Retrospective Study. Integr Cancer Ther 2018;17:431-6. [PMID: 28745082 DOI: 10.1177/1534735417722223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
299 Seki T, Tamai T, Ikeda K, Imamura M, Nishimura A, Yamashiki N, Nakagawa T, Inoue K. Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region: . European Journal of Gastroenterology & Hepatology 2001;13:291-4. [DOI: 10.1097/00042737-200103000-00014] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
300 Uehara T, Hirooka M, Ishida K, Hiraoka A, Kumagi T, Kisaka Y, Hiasa Y, Onji M. Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites. J Gastroenterol. 2007;42:306-311. [PMID: 17464460 DOI: 10.1007/s00535-006-1949-0] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 5.4] [Reference Citation Analysis]
301 D'ippolito G, Goldberg S. Radiofrequency ablation of hepatic tumors. Techniques in Vascular and Interventional Radiology 2002;5:141-55. [DOI: 10.1053/tvir.2002.36423] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
302 Ohki T, Tateishi R, Akahane M, Mikami S, Sato M, Uchino K, Arano T, Enooku K, Kondo Y, Yamashiki N. CT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: a randomized controlled trial. Am J Gastroenterol. 2013;108:1305-1313. [PMID: 23629602 DOI: 10.1038/ajg.2013.109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
303 Günther RW, Bücker A, Adam G. Interventional magnetic resonance: Realistic prospect or wishful thinking? Cardiovasc Intervent Radiol 1999;22:187-95. [DOI: 10.1007/s002709900364] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
304 Varghese T, Zagzebski J, Chen Q, Techavipoo U, Frank G, Johnson C, Wright A, Lee F. Ultrasound monitoring of temperature change during radiofrequency ablation: preliminary in-vivo results. Ultrasound in Medicine & Biology 2002;28:321-9. [DOI: 10.1016/s0301-5629(01)00519-1] [Cited by in Crossref: 110] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
305 Kettenbach J, Blum M, Kilanowicz E, Schwaighofer SM, Lammer J. [Percutaneous radiofrequency ablation of liver cell carcinoma: a current overview]. Radiologe. 2004;44:330-338. [PMID: 15045198 DOI: 10.1007/s00117-004-1031-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
306 Goodman M, Geller DA. Radiofrequency Ablation of Hepatocellular Carcinoma. In: Carr BI, editor. Hepatocellular Cancer. Totowa: Humana Press; 2005. pp. 171-83. [DOI: 10.1007/978-1-59259-844-1_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
307 Goldberg SN. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 2001;13:129-47. [PMID: 11369525 DOI: 10.1016/s0929-8266(01)00126-4] [Cited by in Crossref: 279] [Cited by in F6Publishing: 53] [Article Influence: 14.0] [Reference Citation Analysis]
308 Nakai M, Sato M, Kawai N, Minamiguchi H, Masuda M, Tanihata H, Takeuchi T, Terada M, Kishi K. Hepatocellular carcinoma: involvement of the internal mammary artery. Radiology. 2001;219:147-152. [PMID: 11274549 DOI: 10.1148/radiology.219.1.r01mr28147] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
309 Gervais DA, Mcgovern FJ, Arellano RS, Mcdougal WS, Mueller PR. Renal Cell Carcinoma: Clinical Experience and Technical Success with Radio-frequency Ablation of 42 Tumors. Radiology 2003;226:417-24. [DOI: 10.1148/radiol.2262012062] [Cited by in Crossref: 314] [Cited by in F6Publishing: 249] [Article Influence: 17.4] [Reference Citation Analysis]
310 Nakazawa T, Kokubu S, Shibuya A, Ono K, Watanabe M, Hidaka H, Tsuchihashi T, Saigenji K. Radiofrequency Ablation of Hepatocellular Carcinoma: Correlation Between Local Tumor Progression After Ablation and Ablative Margin. American Journal of Roentgenology 2007;188:480-8. [DOI: 10.2214/ajr.05.2079] [Cited by in Crossref: 242] [Cited by in F6Publishing: 88] [Article Influence: 17.3] [Reference Citation Analysis]
311 Yang W, Johnson P. Monitoring response to treatment in liver tumours. Best Practice & Research Clinical Gastroenterology 1999;13:637-54. [DOI: 10.1053/bega.1999.0053] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
312 Shiina S. Japanese experience in ablation therapies for hepatocellular carcinoma. Hepatology Research 2007;37:S223-9. [DOI: 10.1111/j.1872-034x.2007.00189.x] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
313 Gazelle GS, Mcmahon PM, Beinfeld MT, Halpern EF, Weinstein MC. Metastatic Colorectal Carcinoma: Cost-effectiveness of Percutaneous Radiofrequency Ablation versus That of Hepatic Resection. Radiology 2004;233:729-39. [DOI: 10.1148/radiol.2333032052] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
314 Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 2003;10:1059-1069. [PMID: 14597445 DOI: 10.1245/aso.2003.03.026] [Cited by in Crossref: 215] [Cited by in F6Publishing: 67] [Article Influence: 12.6] [Reference Citation Analysis]
315 Marin D, Cappabianca S, Serra N, Sica A, Lassandro F, D'Angelo R, La Porta M, Fiore F, Somma F. CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review. Gastroenterol Res Pract 2015;2015:670965. [PMID: 26798332 DOI: 10.1155/2015/670965] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
316 Cano-Espinosa C, Gonzalez G, Washko GR, Cazorla M, Estepar RSJ. Biomarker Localization From Deep Learning Regression Networks. IEEE Trans Med Imaging 2020;39:2121-32. [PMID: 31940523 DOI: 10.1109/TMI.2020.2965486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
317 Patti JW, Neeman Z, Wood BJ. Radiofrequency ablation for cancer-associated pain. J Pain 2002;3:471-3. [PMID: 14622733 DOI: 10.1054/jpai.2002.126785] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
318 Buscarini E, Savoia A, Brambilla G, Menozzi F, Reduzzi L, Strobel D, Hänsler J, Buscarini L, Gaiti L, Zambelli A. Radiofrequency thermal ablation of liver tumors. Eur Radiol. 2005;15:884-894. [PMID: 15754165 DOI: 10.1007/s00330-005-2652-x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
319 Kallwitz ER, Cotler SJ. Screening for Hepatocellular Carcinoma in Clinical Practice: Miles to Go Before We Sleep. Journal of Clinical Gastroenterology 2007;41:729-30. [DOI: 10.1097/mcg.0b013e3180544951] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
320 Miyayama S, Yamashiro M, Ikuno M, Okumura K, Yoshida M. Ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinoma guided by automated tumor-feeders detection software: technical success and short-term tumor response. Abdom Imaging 2014;39:645-56. [DOI: 10.1007/s00261-014-0094-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
321 Labori KJ, Schulz A, Drolsum A, Guren MG, Kløw NE, Bjørnbeth BA. Radiofrequency ablation of unresectable colorectal liver metastases: trends in management and outcome during a decade at a single center. Acta Radiol Open. 2015;4:2058460115580877. [PMID: 26346740 DOI: 10.1177/2058460115580877] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
322 Casaccia M, Andorno E, Nardi I, Troilo B, Barabino G, Santori G, Valente U. Laparoscopic US-Guided Radiofrequency Ablation of Unresectable Hepatocellular Carcinoma in Liver Cirrhosis: Feasibility and Clinical Outcome. Journal of Laparoendoscopic & Advanced Surgical Techniques 2008;18:797-801. [DOI: 10.1089/lap.2008.0039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
323 Adam A. Interventional radiology in the treatment of hepatic metastases. Cancer Treat Rev 2002;28:93-9. [PMID: 12297117 DOI: 10.1053/ctrv.2002.9258] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
324 Aschoff AJ, Sulman A, Martinez M, Duerk JL, Resnick MI, Maclennan GT, Lewin JS. Perfusion-Modulated MR Imaging—Guided Radiofrequency Ablation of the Kidney in a Porcine Model. American Journal of Roentgenology 2001;177:151-8. [DOI: 10.2214/ajr.177.1.1770151] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
325 Saab S, Ly D, Nieto J, Kanwal F, Lu D, Raman S, Amado R, Nuesse B, Durazo F, Han S. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl. 2003;9:672-681. [PMID: 12827551 DOI: 10.1053/jlts.2003.50120] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
326 Mangia A, Bellini D, Cillo U, Laghi A, Pelle G, Valori VM, Caturelli E. Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence. BMC Gastroenterol 2020;20:251. [PMID: 32746786 DOI: 10.1186/s12876-020-01391-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
327 Lefevre JH, Parc Y, Lewin M, Bennis M, Tiret E, Parc R. Radiofrequency ablation for recurrent pelvic cancer. Colorectal Dis 2008;10:781-4. [PMID: 18028468 DOI: 10.1111/j.1463-1318.2007.01425.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
328 Sabharwal R, Vladica P. Renal tumors: technical success and early clinical experience with radiofrequency ablation of 18 tumors. Cardiovasc Intervent Radiol 2006;29:202-9. [PMID: 16447001 DOI: 10.1007/s00270-005-0069-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
329 Alvarado R, Mahon B, Valadez C, Caufield M, Wadhwani S, Hambleton C, Siziopikou KP, Dickler AT, Gatta J, Dowlatshahi K. Thermal ablation of the goat mammary gland as a model for post-lumpectomy treatment of breast cancer: preliminary observations. Int J Hyperthermia 2009;25:47-55. [PMID: 19219700 DOI: 10.1080/02656730802322946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
330 Campbell C, Soulen MC, Horii SC, Seigelman ES, Rubesin SE, Vaughn DJ. Transrectal Radiofrequency Ablation for Pelvic Recurrence of Bladder Cancer: Case Report and Review of Complications. Journal of Vascular and Interventional Radiology 2005;16:1027-32. [DOI: 10.1097/01.rvi.0000161145.97509.a1] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
331 Kosaka Y, Kimura T, Kawaoka T, Ogawa Y, Amioka K, Naruto K, Yoshikawa Y, Kikukawa C, Suehiro Y, Yamaoka K, Ando Y, Uchikawa S, Morio K, Nakahara T, Murakami E, Takahashi S, Tsuge M, Hiramatsu A, Imamura M, Chosa K, Awai K, Nagata Y, Chayama K, Aikata H. Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein. Liver Cancer 2021;10:151-60. [PMID: 33977091 DOI: 10.1159/000513706] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
332 Miyaki D, Aikata H, Honda Y, Naeshiro N, Nakahara T, Tanaka M, Nagaoki Y, Kawaoka T, Takaki S, Waki K. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma according to Child-Pugh classification. J Gastroenterol Hepatol. 2012;27:1850-1857. [PMID: 23020312 DOI: 10.1111/j.1440-1746.2012.07276.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
333 Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy. Cancer. 2002;95:2353-2360. [PMID: 12436442 DOI: 10.1002/cncr.10966] [Cited by in Crossref: 105] [Cited by in F6Publishing: 89] [Article Influence: 5.5] [Reference Citation Analysis]
334 Rhim H, Dodd GD. Radiofrequency thermal ablation of liver tumors. J Clin Ultrasound 1999;27:221-9. [DOI: 10.1002/(sici)1097-0096(199906)27:5<221::aid-jcu1>3.0.co;2-t] [Cited by in Crossref: 88] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
335 Machi J, Oishi AJ, Furumoto NL, Oishi RH. Sonographically guided radio frequency thermal ablation for unresectable recurrent tumors in the retroperitoneum and the pelvis. J Ultrasound Med 2003;22:507-13. [PMID: 12751862 DOI: 10.7863/jum.2003.22.5.507] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
336 Nishikawa H, Inuzuka T, Takeda H, Nakajima J, Sakamoto A, Henmi S, Matsuda F, Eso Y, Ishikawa T, Saito S. Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation. J Gastroenterol. 2011;46:1418-1426. [PMID: 21845378 DOI: 10.1007/s00535-011-0452-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
337 Venkatesan AM, Gervais DA, Mueller PR. Percutaneous radiofrequency thermal ablation of primary and metastatic hepatic tumors: current concepts and review of the literature. Semin Intervent Radiol. 2006;23:73-84. [PMID: 21326722 DOI: 10.1055/s-2006-939843] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
338 Iwasa S, Ikeda M, Okusaka T, Ueno H, Morizane C, Nakachi K, Mitsunaga S, Kondo S, Hagihara A, Shimizu S. Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. Jpn J Clin Oncol. 2011;41:770-775. [PMID: 21459893 DOI: 10.1093/jjco/hyr037] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
339 Garcea G, Lloyd TD, Aylott C, Maddern G, Berry DP. The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer 2003;39:2150-64. [PMID: 14522372 DOI: 10.1016/s0959-8049(03)00553-7] [Cited by in Crossref: 68] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
340 Wood BJ, Poon RT, Locklin JK, Dreher MR, Ng KK, Eugeni M, Seidel G, Dromi S, Neeman Z, Kolf M, Black CD, Prabhakar R, Libutti SK. Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J Vasc Interv Radiol 2012;23:248-55.e7. [PMID: 22178041 DOI: 10.1016/j.jvir.2011.10.018] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 8.9] [Reference Citation Analysis]
341 Buscarini L, Buscarini E. Percutaneous ultrasound-guided radiofrequency ablation of liver tumors. Liver Transpl 1999;5:255-6. [DOI: 10.1002/lt.500050313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
342 Choi D, Lim HK, Kim SH, Lee WJ, Jang HJ, Lee JY, Paik SW, Koh KC, Lee JH. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology. 2000;217:558-563. [PMID: 11058660 DOI: 10.1148/radiology.217.2.r00oc07558] [Cited by in Crossref: 106] [Cited by in F6Publishing: 86] [Article Influence: 5.0] [Reference Citation Analysis]
343 Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K. Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma. Cancer 2001;91:1342-8. [DOI: 10.1002/1097-0142(20010401)91:7<1342::aid-cncr1137>3.0.co;2-0] [Cited by in Crossref: 54] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
344 Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T, Omata M. Percutaneous radiofrequency ablation for hepatocellular carcinoma: An analysis of 1000 cases. Cancer 2005;103:1201-9. [DOI: 10.1002/cncr.20892] [Cited by in Crossref: 553] [Cited by in F6Publishing: 481] [Article Influence: 34.6] [Reference Citation Analysis]
345 Hwang JJ, Walther MM, Pautler SE, Coleman JA, Hvizda J, Peterson J, Linehan WM, Wood BJ. Radio frequency ablation of small renal tumors:: intermediate results. J Urol 2004;171:1814-8. [PMID: 15076283 DOI: 10.1097/01.ju.0000119905.72574.de] [Cited by in Crossref: 112] [Cited by in F6Publishing: 86] [Article Influence: 6.6] [Reference Citation Analysis]
346 Fujino H, Kimura T, Aikata H, Miyaki D, Kawaoka T, Kan H, Fukuhara T, Kobayashi T, Naeshiro N, Honda Y, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Hyogo H, Takahashi S, Yoshimatsu R, Yamagami T, Kenjo M, Nagata Y, Awai K, Chayama K. Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma. Hepatol Res. 2015;45:607-617. [PMID: 25052365 DOI: 10.1111/hepr.12392] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
347 Watkins T, Parkinson R. Percutaneous radiofrequency ablation of renal tumours: Case series of 11 tumours and review of published work. Australas Radiol 2007;51:412-9. [DOI: 10.1111/j.1440-1673.2007.01862.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
348 Cedrone A, Pompili M, Sallustio G, Lorenzelli GP, Gasbarrini G, Rapaccini GL. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures. Am J Gastroenterol. 2001;96:1854-1859. [PMID: 11419839 DOI: 10.1111/j.1572-0241.2001.03883.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
349 Kudo K, Moriyasu F, Mine Y, Miyata Y, Sugimoto K, Metoki R, Kamamoto H, Suzuki S, Shimizu M, Miyahara T, Yokoi M, Horibe T, Yamagata H. Preoperative RFA simulation for liver cancer using a CT virtual ultrasound system. European Journal of Radiology 2007;61:324-31. [DOI: 10.1016/j.ejrad.2006.09.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
350 Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47:82-89. [PMID: 18008357 DOI: 10.1002/hep.21933] [Cited by in Crossref: 705] [Cited by in F6Publishing: 611] [Article Influence: 54.2] [Reference Citation Analysis]
351 Kim SH, Lim HK, Choi D, Lee WJ, Kim SH, Kim MJ, Kim CK, Jeon YH, Lee JM, Rhim H. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am J Roentgenol. 2006;186:S327-S333. [PMID: 16632696 DOI: 10.2214/ajr.05.0350] [Cited by in Crossref: 45] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
352 Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, Konishi J. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology. 2002;223:331-337. [PMID: 11997534 DOI: 10.1148/radiol.2232010775] [Cited by in Crossref: 372] [Cited by in F6Publishing: 316] [Article Influence: 19.6] [Reference Citation Analysis]
353 Kondo Y, Yoshida H, Tateishi R, Shiina S, Mine N, Yamashiki N, Sato S, Kato N, Kanai F, Yanase M. Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22:197-203. [PMID: 17295871 DOI: 10.1111/j.1440-1746.2006.04456.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
354 Imamura J, Tateishi R, Shiina S, Goto E, Sato T, Ohki T, Masuzaki R, Goto T, Yoshida H, Kanai F, Hamamura K, Obi S, Yoshida H, Omata M. Neoplastic Seeding After Radiofrequency Ablation for Hepatocellular Carcinoma. The American Journal of Gastroenterology 2008;103:3057-62. [DOI: 10.1111/j.1572-0241.2008.02153.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 5.2] [Reference Citation Analysis]
355 Dodd GD, Soulen MC, Kane RA, Livraghi T, Lees WR, Yamashita Y, Gillams AR, Karahan OI, Rhim H. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics. 2000;20:9-27. [PMID: 10682768 DOI: 10.1148/radiographics.20.1.g00ja019] [Cited by in Crossref: 436] [Cited by in F6Publishing: 341] [Article Influence: 20.8] [Reference Citation Analysis]
356 Wong J, Lee K, Lee P, Ho S, Yu S, Ng W, Cheung Y, Tsang Y, Ling E, Lai P. Radiofrequency Ablation for 110 Malignant Liver Tumours: Preliminary Results on Percutaneous and Surgical Approaches. Asian Journal of Surgery 2009;32:13-20. [DOI: 10.1016/s1015-9584(09)60003-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
357 Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. The Lancet 2003;362:1907-17. [DOI: 10.1016/s0140-6736(03)14964-1] [Cited by in Crossref: 3076] [Cited by in F6Publishing: 1235] [Article Influence: 170.9] [Reference Citation Analysis]
358 Yamagami T, Kato T, Tanaka O, Hirota T, Nishimura T. Radiofrequency Ablation Therapy of Remnant Colorectal Liver Metastases after a Course of Hepatic Arterial Infusion Chemotherapy. Journal of Vascular and Interventional Radiology 2005;16:549-54. [DOI: 10.1097/01.rvi.0000153439.89142.1d] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
359 Hänsler J, Frieser M, Schaber S, Kutschall C, Bernatik T, Müller W, Becker D, Hahn EG, Strobel D. Radiofrequency ablation of hepatocellular carcinoma with a saline solution perfusion device: a pilot study. J Vasc Interv Radiol. 2003;14:575-580. [PMID: 12761310 DOI: 10.1097/01.rvi.0000071096.76348.3b] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
360 Meloni MF, Andreano A, Laeseke PF, Livraghi T, Sironi S, Lee FT Jr. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates. Radiology 2009;253:861-9. [PMID: 19709994 DOI: 10.1148/radiol.2533081968] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 6.9] [Reference Citation Analysis]
361 Imaeda M, Ishikawa H, Yoshida Y, Takahashi T, Ohkubo Y, Musha A, Komachi M, Nakazato Y, Nakano T. Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats. J Radiat Res 2014;55:665-73. [PMID: 24566720 DOI: 10.1093/jrr/rru005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
362 Pacella CM, Bizzarri G, Francica G, Forlini G, Petrolati A, Valle D, Anelli V, Bianchini A, Nuntis SD, Pacella S, Rossi Z, Osborn J, Stasi R. Analysis of factors predicting survival in patients with hepatocellular carcinoma treated with percutaneous laser ablation. Journal of Hepatology 2006;44:902-9. [DOI: 10.1016/j.jhep.2006.01.031] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
363 Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol. 2005;23:1358-1364. [PMID: 15684312 DOI: 10.1200/jco.2005.12.039] [Cited by in Crossref: 185] [Cited by in F6Publishing: 48] [Article Influence: 11.6] [Reference Citation Analysis]
364 Walther MCCM, Shawker TH, Libutti SK, Lubensky I, Choyke PL, Venzon D, Linehan WM. A PHASE 2 STUDY OF RADIO FREQUENCY INTERSTITIAL TISSUE ABLATION OF LOCALIZED RENAL TUMORS. Journal of Urology 2000;163:1424-7. [DOI: 10.1016/s0022-5347(05)67634-3] [Cited by in Crossref: 67] [Article Influence: 3.2] [Reference Citation Analysis]
365 Abdellaoui A, Watkinson AF. Radiofrequency ablation of renal tumors. Future Oncology 2008;4:103-11. [DOI: 10.2217/14796694.4.1.103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
366 Padma S, Martinie JB, Iannitti DA. Liver tumor ablation: Percutaneous and open approaches. J Surg Oncol. 2009;100:619-634. [PMID: 20017157 DOI: 10.1002/jso.21364] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 6.2] [Reference Citation Analysis]
367 Peng ZW, Zhang YJ, Chen MS, Liang HH, Li JQ, Zhang YQ, Lau WY. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Surg Oncol. 2008;17:23-31. [PMID: 17869095 DOI: 10.1016/j.suronc.2007.08.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
368 Zagoria RJ. “Percutaneous RF Interstitial Thermal Ablation in the Treatment of Hepatic Cancer”— A Commentary. American Journal of Roentgenology 2006;187:1149-50. [DOI: 10.2214/ajr.06.0426] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
369 Hirooka M, Iuchi H, Kumagi T, Shigematsu S, Hiraoka A, Uehara T, Kurose K, Horiike N, Onji M. Virtual Sonographic Radiofrequency Ablation of Hepatocellular Carcinoma Visualized on CT but Not on Conventional Sonography. American Journal of Roentgenology 2006;186:S255-60. [DOI: 10.2214/ajr.04.1252] [Cited by in Crossref: 62] [Cited by in F6Publishing: 12] [Article Influence: 4.1] [Reference Citation Analysis]
370 Netto GJ, Altrabulsi B, Katabi N, Martin P, Burt K, Levy M, Sanchez E, Watkins DL, Jennings L, Klintmalm G, Goldstein R. Radio-frequency ablation of hepatocellular carcinoma before liver transplantation: a histologic and 'TUNEL' study. Liver Int. 2006;26:746-751. [PMID: 16842333 DOI: 10.1111/j.1478-3231.2006.01278.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
371 Yoon SS, Tanabe KK. Multidisciplinary management of metastatic colorectal cancer. Surg Oncol 1998;7:197-207. [PMID: 10677170 DOI: 10.1016/s0960-7404(99)00022-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
372 Livraghi T, Goldberg SN, Solbiati L, Meloni F, Ierace T, Gazelle GS. Percutaneous Radio-frequency Ablation of Liver Metastases from Breast Cancer: Initial Experience in 24 Patients. Radiology 2001;220:145-9. [DOI: 10.1148/radiology.220.1.r01jl01145] [Cited by in Crossref: 134] [Cited by in F6Publishing: 89] [Article Influence: 6.7] [Reference Citation Analysis]
373 Scudamore CH, Patterson EJ, Shapiro AMJ, Buczkowski AK. Liver Tumor Ablation Techniques. Journal of Investigative Surgery 2009;10:157-64. [DOI: 10.3109/08941939709032152] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
374 Uehara T, Hirooka M, Kisaka Y, Abe M, Hiasa Y, Onji M. Usefulness of the hyperechoic rim for assessing the therapeutic efficacy of radiofrequency ablation in hepatocellular carcinoma patients. Hepatology Research 2009;39:954-62. [DOI: 10.1111/j.1872-034x.2009.00537.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
375 Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg. 1998;227:559-565. [PMID: 9563546 DOI: 10.1097/00000658-199804000-00018] [Cited by in Crossref: 378] [Cited by in F6Publishing: 313] [Article Influence: 16.4] [Reference Citation Analysis]
376 Wex C, Stoll A, Fröhlich M, Arndt S, Lippert H. Mechanics of fresh, frozen-thawed and heated porcine liver tissue. International Journal of Hyperthermia 2014;30:271-83. [DOI: 10.3109/02656736.2014.924161] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
377 Lin SM, Lin CJ, Chung HJ, Hsu CW, Peng CY. Power rolloff during interactive radiofrequency ablation can enhance necrosis when treating hepatocellular carcinoma. AJR Am J Roentgenol 2003;180:151-7. [PMID: 12490494 DOI: 10.2214/ajr.180.1.1800151] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
378 Solbiati L, Goldberg SN, Ierace T, Dellanoce M, Livraghi T, Gazelle GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent--early experience. Radiology. 1999;211:643-649. [PMID: 10352586 DOI: 10.1148/radiology.211.3.r99jn06643] [Cited by in Crossref: 154] [Cited by in F6Publishing: 127] [Article Influence: 7.0] [Reference Citation Analysis]
379 Leen E, Horgan PG. Radiofrequency ablation of colorectal liver metastases. Surgical Oncology 2007;16:47-51. [DOI: 10.1016/j.suronc.2007.04.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
380 Asahina Y, Nakanishi H, Izumi N. Laparoscopic radiofrequency ablation for hepatocellular carcinoma. Dig Endosc. 2009;21:67-72. [PMID: 19691776 DOI: 10.1111/j.1443-1661.2009.00844.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
381 Kim JW, Shin JH, Kim PN, Shin YM, Won HJ, Ko GY, Yoon HK. Embolization for Bleeding after Hepatic Radiofrequency Ablation. J Vasc Interv Radiol 2017;28:356-365.e2. [PMID: 28012690 DOI: 10.1016/j.jvir.2016.09.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
382 Kitamoto M, Imagawa M, Yamada H, Watanabe C, Sumioka M, Satoh O, Shimamoto M, Kodama M, Kimura S, Kishimoto K. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. AJR Am J Roentgenol. 2003;181:997-1003. [PMID: 14500217 DOI: 10.2214/ajr.181.4.1810997] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
383 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol. 2010;2:417-424. [PMID: 21179308 DOI: 10.4329/wjr.v2.i11.417] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 53] [Article Influence: 6.0] [Reference Citation Analysis]
384 Aschoff AJ, Rafie N, Jesberger JA, Duerk JL, Lewin JS. Thermal lesion conspicuity following interstitial radiofrequency thermal tumor ablation in humans: A comparison of STIR, turbo spin-echo T2-weighted, and contrast-enhanced T1-weighted MR images at 0.2 T. J Magn Reson Imaging 2000;12:584-9. [DOI: 10.1002/1522-2586(200010)12:4<584::aid-jmri10>3.0.co;2-w] [Cited by in Crossref: 31] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
385 Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999;210:655-661. [PMID: 10207464 DOI: 10.1148/radiology.210.3.r99fe40655] [Cited by in Crossref: 940] [Cited by in F6Publishing: 794] [Article Influence: 42.7] [Reference Citation Analysis]
386 Tateishi R, Fujiwara N. Precision Locoregional Therapies for Hepatocellular Carcinoma: Percutaneous Ablation and Radiotherapy. In: Hoshida Y, editor. Hepatocellular Carcinoma. Cham: Springer International Publishing; 2019. pp. 195-224. [DOI: 10.1007/978-3-030-21540-8_10] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
387 Lim HK, Choi D, Lee WJ, Kim SH, Lee SJ, Jang HJ, Lee JH, Lim JH, Choo IW. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology. 2001;221:447-454. [PMID: 11687689 DOI: 10.1148/radiol.2212010446] [Cited by in Crossref: 181] [Cited by in F6Publishing: 152] [Article Influence: 9.1] [Reference Citation Analysis]
388 Gillams AR. Radiofrequency ablation in the management of liver tumours. Eur J Surg Oncol 2003;29:9-16. [PMID: 12559069 DOI: 10.1053/ejso.2002.1346] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
389 Mok TS, Choi E, Yau D, Johri A, Yeo W, Chan AT, Wong C. Effects of patupilone (epothilone B; EPO906), a novel chemotherapeutic agent, in hepatocellular carcinoma: an in vitro study. Oncology 2006;71:292-6. [PMID: 17657173 DOI: 10.1159/000106450] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
390 Decadt B, Siriwardena AK. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol. 2004;5:550-560. [PMID: 15337485 DOI: 10.1016/s1470-2045(04)01567-0] [Cited by in Crossref: 135] [Cited by in F6Publishing: 30] [Article Influence: 7.9] [Reference Citation Analysis]
391 Ishii T, Numata K, Hao Y, Doba N, Hara K, Kondo M, Tanaka K, Maeda S. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation. Eur J Radiol 2017;89:234-41. [PMID: 28034569 DOI: 10.1016/j.ejrad.2016.12.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
392 Rivaz H, Fleming I, Assumpcao L, Fichtinger G, Hamper U, Choti M, Hager G, Boctor E. Ablation monitoring with elastography: 2D in-vivo and 3D ex-vivo studies. Med Image Comput Comput Assist Interv 2008;11:458-66. [PMID: 18982637 DOI: 10.1007/978-3-540-85990-1_55] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
393 Hall TJ, Barbone P, Oberai AA, Jiang J, Dord JF, Goenezen S, Fisher TG. Recent results in nonlinear strain and modulus imaging. Curr Med Imaging Rev 2011;7:313-27. [PMID: 22754425 DOI: 10.2174/157340511798038639] [Cited by in Crossref: 52] [Cited by in F6Publishing: 14] [Article Influence: 5.2] [Reference Citation Analysis]
394 Tatsugami F, Matsuki M, Nakai G, Tanikake M, Yoshikawa S, Narabayashi I, Miyaji K, Asai A, Fujiwara S, Hongo Y, Katsu K. Hepatic Computed Tomography for Simultaneous Depiction of Hepatocellular Carcinoma, Intrahepatic Portal Veins, and Hepatic Veins in Real-time Virtual Sonography: Initial Experience. Journal of Ultrasound in Medicine 2007;26:1065-9. [DOI: 10.7863/jum.2007.26.8.1065] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
395 Siperstein AE, Rogers SJ, Hansen PD, Gitomirsky A. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery. 1997;122:1147-1154; discussion 1147-1154;. [PMID: 9426432 DOI: 10.1016/s0039-6060(97)90221-x] [Cited by in Crossref: 171] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
396 Tateishi R, Shiina S, Akahane M, Sato J, Kondo Y, Masuzaki R, Nakagawa H, Asaoka Y, Goto T, Otomo K, Omata M, Yoshida H, Koike K. Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma. PLoS One 2013;8:e59040. [PMID: 23593129 DOI: 10.1371/journal.pone.0059040] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
397 Hyodoh H, Furuse M, Kawamoto C, Isoda N, Ido K, Saito K. Microwave coagulation therapy: Ex vivo comparison of MR imaging and histopathology. J Magn Reson Imaging 2000;11:168-73. [DOI: 10.1002/(sici)1522-2586(200002)11:2<168::aid-jmri14>3.0.co;2-w] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
398 Tarantino L, Sordelli I, Nocera V, Piscopo A, Ripa C, Parmeggiani D, Sperlongano P. Ablation of large HCCs using a new saline-enhanced expandable radiofrequency device(). J Ultrasound 2009;12:69-74. [PMID: 23396886 DOI: 10.1016/j.jus.2009.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
399 Qiu-Jie S, Zhi-Yu H, Xiao-Xia N, Wen-Yuan S, Yuan-Yuan S, Liu H, Xin L, Ping L. Feasible temperature of percutaneous microwave ablation of dog liver abutting the bowel. Int J Hyperthermia 2011;27:124-31. [PMID: 21204623 DOI: 10.3109/02656736.2010.508763] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
400 Kuszyk BS, Boitnott JK, Choti MA, Bluemke DA, Sheth S, Magee CA, Horton KM, Eng J, Fishman EK. Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model. Radiology. 2000;217:477-486. [PMID: 11058649 DOI: 10.1148/radiology.217.2.r00nv41477] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 3.3] [Reference Citation Analysis]
401 Liu D, Brace CL. Numerical simulation of microwave ablation incorporating tissue contraction based on thermal dose. Phys Med Biol 2017;62:2070-86. [PMID: 28151729 DOI: 10.1088/1361-6560/aa5de4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
402 Cheung TT, Fan ST, Chu FS, Jenkins CR, Chok KS, Tsang SH, Dai WC, Chan AC, Chan SC, Yau TC, Poon RT, Lo CM. Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma. HPB (Oxford) 2013;15:567-73. [PMID: 23458602 DOI: 10.1111/hpb.12025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
403 Chen X, Saidel GM. Mathematical Modeling of Thermal Ablation in Tissue Surrounding a Large Vessel. Journal of Biomechanical Engineering 2009;131:011001. [DOI: 10.1115/1.2965374] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
404 Kuroda H, Ushio A, Miyamoto Y, Sawara K, Oikawa K, Kasai K, Endo R, Takikawa Y, Kato A, Suzuki K. Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: a one-year prospective trial. J Gastroenterol Hepatol. 2010;25:1550-1555. [PMID: 20796154 DOI: 10.1111/j.1440-1746.2010.06306.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
405 Perry JF, Strasser SI, George J, Farrell GC, Mccaughan GW. Pharmacotherapy of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2005;4:2175-85. [DOI: 10.1517/14656566.4.12.2175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
406 Chen M, Wu W, Yang W, Dai Y, Gao W, Yin S, Yan K. The Use of Contrast-Enhanced Ultrasonography in the Selection of Patients With Hepatocellular Carcinoma for Radio Frequency Ablation Therapy. Journal of Ultrasound in Medicine 2007;26:1055-63. [DOI: 10.7863/jum.2007.26.8.1055] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
407 Goode JA, Sabharwal T, Adam A. Percutaneous Ablation of Hepatic Metastases. In: Lencioni R, Cioni D, Bartolozzi C, editors. Focal Liver Lesions. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 337-48. [DOI: 10.1007/3-540-26354-3_24] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
408 Kitada T, Murakami T, Kuzushita N, Minamitani K, Nakajo K, Osuga K, Miyoshi E, Nakamura H, Kishino B, Tamura S, Hayashi N. Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas. Hepatol Res 2008;38:565-71. [PMID: 18218008 DOI: 10.1111/j.1872-034X.2007.00308.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
409 Heniford BT, Arca MJ, Iannitti DA, Walsh RM, Gagner M. Laparoscopic cryoablation of hepatic metastases. Semin Surg Oncol 1998;15:194-201. [DOI: 10.1002/(sici)1098-2388(199810/11)15:3<194::aid-ssu9>3.0.co;2-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
410 Modesto A, Giron J, Massabeau C, Sans N, Berjaud J, Mazieres J. Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: Case report and review of the literature. Lung Cancer 2013;80:341-3. [DOI: 10.1016/j.lungcan.2013.02.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
411 Sato M, Tateishi R, Yasunaga H, Matsui H, Horiguchi H, Fushimi K, Koike K. Mortality and hemorrhagic complications associated with radiofrequency ablation for treatment of hepatocellular carcinoma in patients on hemodialysis for end-stage renal disease: A nationwide survey. J Gastroenterol Hepatol. 2017;32:1873-1878. [PMID: 28266772 DOI: 10.1111/jgh.13780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
412 Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach”. Cancer. 2003;97:3027-3035. [PMID: 12784338 DOI: 10.1002/cncr.11426] [Cited by in Crossref: 222] [Cited by in F6Publishing: 179] [Article Influence: 12.3] [Reference Citation Analysis]
413 Ruzzenente A, Guglielmi A, Sandri M, Campagnaro T, Valdegamberi A, Conci S, Bagante F, Turcato G, D'Onofrio M, Iacono C. Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study. J Gastrointest Surg. 2012;16:301-11; discussion 311. [PMID: 22095524 DOI: 10.1007/s11605-011-1745-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
414 Tan D, Mohamad NA, Wong YH, Yeong CH, Cheah PL, Sulaiman N, Abdullah BJJ, Fabell MK, Lim KS. Experimental assessment on feasibility of computed tomography-based thermometry for radiofrequency ablation on tissue equivalent polyacrylamide phantom. International Journal of Hyperthermia 2019;36:553-60. [DOI: 10.1080/02656736.2019.1610800] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
415 Ueshima K, Kudo M, Tanaka M, Kumada T, Chung H, Hagiwara S, Inoue T, Yada N, Kitai S. Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil. Liver Cancer 2015;4:263-73. [PMID: 26734580 DOI: 10.1159/000367751] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
416 Morimoto M, Sugimori K, Shirato K, Kokawa A, Tomita N, Saito T, Tanaka N, Nozawa A, Hara M, Sekihara H. Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods. Hepatology. 2002;35:1467-1475. [PMID: 12029632 DOI: 10.1053/jhep.2002.33635] [Cited by in Crossref: 119] [Cited by in F6Publishing: 113] [Article Influence: 6.3] [Reference Citation Analysis]
417 Burdío F, Güemes A, Burdío JM, Castiella T, De Gregorio MA, Lozano R, Livraghi T. Hepatic lesion ablation with bipolar saline-enhanced radiofrequency in the audible spectrum. Academic Radiology 1999;6:680-6. [DOI: 10.1016/s1076-6332(99)80117-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
418 Gadaleta C, Mattioli V, Colucci G, Cramarossa A, Lorusso V, Canniello E, Timurian A, Ranieri G, Fiorentini G, De Lena M. Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am J Roentgenol. 2004;183:361-368. [PMID: 15269026 DOI: 10.2214/ajr.183.2.1830361] [Cited by in Crossref: 73] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
419 Azab M, Zaki S, El-Shetey AG, Abdel-Moty MF, Alnoomani NM, Gomaa AA, Abdel-Fatah S, Mohiy S, Atia F. Radiofrequency ablation combined with percutaneous ethanol injection in patients with hepatocellular carcinoma. Arab J Gastroenterol. 2011;12:113-118. [PMID: 22055587 DOI: 10.1016/j.ajg.2011.07.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
420 Lee JY, Choi BI, Chung YE, Kim MW, Kim SH, Han JK. Clinical value of CT/MR-US fusion imaging for radiofrequency ablation of hepatic nodules. European Journal of Radiology 2012;81:2281-9. [DOI: 10.1016/j.ejrad.2011.08.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
421 Ripley RT, Gajdos C, Reppert AE, Macdermott T, Mccarter MD, Pearlman NW. Sequential radiofrequency ablation and surgical debulking for unresectable colorectal carcinoma: Thermo-surgical ablation: RFA and Debulking for Unresectable CRC. J Surg Oncol 2013;107:144-7. [DOI: 10.1002/jso.23211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
422 Yu HC, Cheng JS, Lai KH, Lin CP, Lo GH, Lin CK, Hsu PI, Chan HH, Lo CC, Tsai WL, Chen WC. Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol 2005;11:1439-44. [PMID: 15770718 DOI: 10.3748/wjg.v11.i10.1439] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
423 Furuse J, Ishii H, Satake M, Onaya H, Nose H, Mikami S, Sakai H, Mera K, Maru Y, Yoshino M. Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma. Am J Clin Oncol. 2003;26:159-164. [PMID: 12714888 DOI: 10.1097/00000421-200304000-00012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
424 Kwan J, Appuhamy C, Lim GHT, Huang IKH, Quek L, Pua U. Safety and Efficacy of Percutaneous Thermal Ablation of Juxta-Cardiac Hepatic Tumours. Cardiovasc Intervent Radiol 2018;41:920-7. [PMID: 29582128 DOI: 10.1007/s00270-018-1938-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
425 Rendon RA, Gertner MR, Sherar MD, Asch MR, Kachura JR, Sweet J, Jewett MA. DEVELOPMENT OF A RADIOFREQUENCY BASED THERMAL THERAPY TECHNIQUE IN AN IN VIVO PORCINE MODEL FOR THE TREATMENT OF SMALL RENAL MASSES. Journal of Urology 2001;166:292-8. [DOI: 10.1016/s0022-5347(05)66148-4] [Cited by in Crossref: 66] [Article Influence: 3.3] [Reference Citation Analysis]
426 Nghiem HV, Francis IR, Fontana R, Hussain H, Platt JF, Higgins E, Bree RL. Computed tomography appearances of hypervascular hepatic tumors after percutaneous radiofrequency ablation therapy. Current Problems in Diagnostic Radiology 2002;31:105-11. [DOI: 10.1067/cdr.2002.125400] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
427 Zhang M, Castaneda B, Christensen J, Saad WE, Bylund K, Hoyt K, Strang JG, Rubens DJ, Parker KJ. Real-time sonoelastography of hepatic thermal lesions in a swine model. Med Phys 2008;35:4132-41. [PMID: 18841866 DOI: 10.1118/1.2968939] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
428 Helton WS, Di Bisceglie A, Chari R, Schwartz M, Bruix J. Treatment strategies for hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2003;7:401-11. [PMID: 12654567 DOI: 10.1016/s1091-255x(02)00161-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
429 Govaert KM, van Kessel CS, Lolkema M, Ruers TJ, Borel Rinkes IH. Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases? Curr Colorectal Cancer Rep. 2012;8:130-137. [PMID: 22611343 DOI: 10.1007/s11888-012-0122-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
430 Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl. 2004;10:S39-S45. [PMID: 14762838 DOI: 10.1002/lt.20040] [Cited by in Crossref: 146] [Cited by in F6Publishing: 146] [Article Influence: 8.6] [Reference Citation Analysis]
431 Honda Y, Takahashi S, Zhang Y, Ono A, Murakami E, Shi N, Kawaoka T, Miki D, Tsuge M, Hiraga N. Effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway. J Gastroenterol Hepatol. 2015;30:619-627. [PMID: 25167891 DOI: 10.1111/jgh.12715] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
432 Yoon DY, Yun EJ, Ku YJ, Baek S, Lim KJ, Seo YL, Yie M. Citation classics in radiology journals: the 100 top-cited articles, 1945-2012. AJR Am J Roentgenol 2013;201:471-81. [PMID: 23971438 DOI: 10.2214/AJR.12.10489] [Cited by in Crossref: 64] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
433 Duerk JL, Butts K, Hwang K, Lewin JS. Pulse Sequences for Interventional Magnetic Resonance Imaging: . Topics in Magnetic Resonance Imaging 2000;11:147-62. [DOI: 10.1097/00002142-200006000-00001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
434 Shin S, Lee JM, Kim KW, Joo I, Han JK, Choi BI, Klotz E. Postablation Assessment Using Follow-Up Registration of CT Images Before and After Radiofrequency Ablation (RFA): Prospective Evaluation of Midterm Therapeutic Results of RFA for Hepatocellular Carcinoma. American Journal of Roentgenology 2014;203:70-7. [DOI: 10.2214/ajr.13.11709] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
435 Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol. 2009;104:514-524. [PMID: 19174803 DOI: 10.1038/ajg.2008.80] [Cited by in Crossref: 166] [Cited by in F6Publishing: 141] [Article Influence: 13.8] [Reference Citation Analysis]
436 Campagnacci R, Guerrieri M, Sanctis AD, Sarnari J, Lezoche E. Laparoscopic Radiofrequency Renal Ablation in Patients with Simultaneous Visceral Tumors: Long-Term Follow-Up. Journal of Endourology 2006;20:321-5. [DOI: 10.1089/end.2006.20.321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
437 Topal B, Aerts R, Penninckx F. Laparoscopic Radiofrequency Ablation of Unresectable Liver Malignancies: Feasibility and Clinical Outcome. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2003;13:11-5. [DOI: 10.1097/00129689-200302000-00003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
438 Jiang J, Varghese T, Brace CL, Madsen EL, Hall TJ, Bharat S, Hobson MA, Zagzebski JA, Lee FT. Young's modulus reconstruction for radio-frequency ablation electrode-induced displacement fields: a feasibility study. IEEE Trans Med Imaging 2009;28:1325-34. [PMID: 19258195 DOI: 10.1109/TMI.2009.2015355] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
439 Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A. Placement of a Sodium Hyaluronate Solution onto the Liver Surface as a Supportive Procedure for Radiofrequency Ablation of Hepatocellular Carcinomas Located on the Liver Surface: A Preliminary Report. Journal of Vascular and Interventional Radiology 2012;23:1639-1645.e1. [DOI: 10.1016/j.jvir.2012.08.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
440 Yamashita H, Nakagawa K, Shiraishi K, Tago M, Igaki H, Nakamura N, Sasano N, Shiina S, Omata M, Ohtomo K. External beam radiotherapy to treat intra- and extra-hepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. J Gastroenterol Hepatol 2006;21:1555-60. [PMID: 16928216 DOI: 10.1111/j.1440-1746.2006.04432.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
441 Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, Cova L, Halpern EF, Gazelle GS. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001;221:159-166. [PMID: 11568334 DOI: 10.1148/radiol.2211001624] [Cited by in Crossref: 644] [Cited by in F6Publishing: 525] [Article Influence: 32.2] [Reference Citation Analysis]
442 Katamura Y, Aikata H, Takaki S, Azakami T, Kawaoka T, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Kenjo M, Toyota N, Ito K, Chayama K. Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis. J Gastroenterol. 2009;44:492-502. [PMID: 19330281 DOI: 10.1007/s00535-009-0033-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
443 White DC, D'Amico TA. Radiofrequency ablation for primary lung cancer and pulmonary metastases. Clin Lung Cancer 2008;9:16-23. [PMID: 18282353 DOI: 10.3816/CLC.2008.n.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
444 Ng KK, Poon RT. Role of radiofrequency ablation for liver malignancies. Surgical Practice 2005;9:94-103. [DOI: 10.1111/j.1744-1633.2005.00265.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
445 Gaiani S, Celli N, Cecilioni L, Piscaglia F, Bolondi L. Percutaneous treatment of hepatocellular carcinoma: REVIEW: PERCUTANEOUS TREATMENT OF HEPATOCELLULAR CARCINOMA. Alimentary Pharmacology & Therapeutics 2003;17:103-10. [DOI: 10.1046/j.1365-2036.17.s2.21.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
446 Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, Kuboki M, Yamamoto S. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas. Journal of Gastroenterology and Hepatology 2009;24:223-7. [DOI: 10.1111/j.1440-1746.2008.05596.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
447 Yoon SS, Tanabe KK. Surgical Treatment and Other Regional Treatments for Colorectal Cancer Liver Metastases. The Oncologist 1999;4:197-208. [DOI: 10.1634/theoncologist.4-3-197] [Cited by in Crossref: 88] [Cited by in F6Publishing: 49] [Article Influence: 4.0] [Reference Citation Analysis]
448 Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST, Wong J. Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg. 2004;239:441-449. [PMID: 15024304 DOI: 10.1097/01.sla.0000118565.21298.0a] [Cited by in Crossref: 146] [Cited by in F6Publishing: 120] [Article Influence: 8.6] [Reference Citation Analysis]
449 Shamim F, Asghar A, Tauheed S, Yahya M. Radiofrequency ablation of hepatocellular carcinomas: A new spectrum of anesthetic experience at a tertiary care hospital in Pakistan. Saudi J Anaesth 2017;11:21-5. [PMID: 28217048 DOI: 10.4103/1658-354X.197367] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
450 Tateishi R, Shiina S, Ohki T, Sato T, Masuzaki R, Imamura J, Goto E, Goto T, Yoshida H, Obi S, Sato S, Kanai F, Yoshida H, Omata M. Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation. J Gastroenterol 2009;44:142-6. [DOI: 10.1007/s00535-008-2247-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
451 Sun Y, Wang Y, Ni X, Gao Y, Shao Q, Liu L, Liang P. Comparison of ablation zone between 915- and 2,450-MHz cooled-shaft microwave antenna: results in in vivo porcine livers. AJR Am J Roentgenol. 2009;192:511-514. [PMID: 19155418 DOI: 10.2214/ajr.07.3828] [Cited by in Crossref: 53] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
452 Nour SG, Lewin JS. Radiofrequency Thermal Ablation: The Role of MR Imaging in Guiding and Monitoring Tumor Therapy. Magnetic Resonance Imaging Clinics of North America 2005;13:561-81. [DOI: 10.1016/j.mric.2005.04.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
453 Mochizuki T, Tsuda T, Sugawara Y, Tanaka H, Kikuchi T, Miyagawa M, Shimizu K, Murase K, Iuchi H, Onji M, Ikezoe J. Tc-99m PMT Hepatobiliary Scintigraphy in the Differential Diagnosis of Extrahepatic Metastases and Hepatocellular Carcinoma: . Clinical Nuclear Medicine 2000;25:991-5. [DOI: 10.1097/00003072-200012000-00006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
454 Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology. 2005;235:299-307. [PMID: 15731369 DOI: 10.1148/radiol.2351031944] [Cited by in Crossref: 152] [Cited by in F6Publishing: 147] [Article Influence: 9.5] [Reference Citation Analysis]
455 Yan K, Chen MH, Yang W, Wang YB, Gao W, Hao CY, Xing BC, Huang XF. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol. 2008;67:336-347. [PMID: 17765421 DOI: 10.1016/j.ejrad.2007.07.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]
456 Goletti O, Lencioni R, Armillotta N, Puglisi A, Lippolis PV, Lorenzetti L, Cioni D, Musco B, Bartolozzi C, Cavina E. Laparoscopic Radiofrequency Thermal Ablation of Hepatocarcinoma: Preliminary Experience: . Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2000;10:284-90. [DOI: 10.1097/00129689-200010000-00005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
457 Wu S, Hou J, Ding Y, Wu F, Hu Y, Jiang Q, Mao P, Yang Y. Cryoablation Versus Radiofrequency Ablation for Hepatic Malignancies: A Systematic Review and Literature-Based Analysis. Medicine (Baltimore). 2015;94:e2252. [PMID: 26656371 DOI: 10.1097/md.0000000000002252] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
458 Jiang HC, Liu LX, Piao DX, Xu J, Zheng M, Zhu AL, Qi SY, Zhang WH, Wu LF. Clinical short-term results of radiofrequency ablation in liver cancers. World J Gastroenterol 2002;8:624-30. [PMID: 12174368 DOI: 10.3748/wjg.v8.i4.624] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.0] [Reference Citation Analysis]
459 Liu D, Brace CL. Evaluation of tissue deformation during radiofrequency and microwave ablation procedures: Influence of output energy delivery. Med Phys 2019;46:4127-34. [PMID: 31260115 DOI: 10.1002/mp.13688] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
460 Chong WK. Radiofrequency Ablation of Liver Tumors: . Journal of Clinical Gastroenterology 2001;32:372-4. [DOI: 10.1097/00004836-200105000-00002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]